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ABSTRACT
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Introduction: While funding for research has declined since 2004, the need for rapid,
innovative, and lifesaving clinical and translational research has never been greater due to the
rise in chronic health conditions, which have resulted in lower life expectancy and higher rates of
mortality and adverse outcomes. Finding effective diagnostic and treatment methods to address
the complex challenges in individual and population health will require a team science approach,
creating the need for multidisciplinary collaboration among practitioners and researchers.

To address this need, the National Institutes of Health (NIH) created the Clinical and
Translational Science Awards (CTSA) program. The CTSA program distributes funds to a
national network of medical research institutions, known as “hubs,” that work together to
improve the translational research process. With this funding, each hub is required to achieve
specific goals to support clinical and translational research teams by providing a variety of
services, including cutting edge use of informatics technologies. As a result, the majority of
CTSA recipients have implemented and maintain data warehouses, which combine disparate data
types from a range of clinical and administrative sources, include data from multiple institutions,
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and support a variety of workflows. These data warehouses provide comprehensive sets of data
that extend beyond the contents of a single EHR system and provide more valuable information
for translational research.

Although significant research has been conducted related to this technology, gaps exist regarding
research team adoption of data warehouses. As a result, more information is needed to
understand how data warehouses are adopted and what outcomes are achieved when using them.
Specifically, this study focuses on three gaps: research team awareness of data warehouses, the
outcomes of data warehouse training for research teams, and how to measure objectively
outcomes achieved after training.

By assessing and measuring data warehouse use, this study aims to provide a greater
understanding of data warehouse adoption and the outcomes achieved. With this understanding,
the most effective and efficient development, implementation, and maintenance strategies can be
used to increase the return on investment for these resource-intensive technologies. In addition,
technologies can be better designed to ensure they are meeting the needs of clinical and
translational science in the 21st century and beyond.

Methods: During the study period, presentations were held to raise awareness of data
warehouse technology. In addition, training sessions were provided that focused on the use of
data warehouses for research projects. To assess the impact of the presentations and training
sessions, pre- and post-assessments gauged knowledge and likelihood to use the technology. As
objective measurements, the number of data warehouse access and training requests were
obtained, and audit trails were reviewed to assess trainee activities within the data warehouse.
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Finally, trainees completed a 30-day post-training assessment to provide information about
barriers and benefits of the technology.

Results: Key study findings suggest that the awareness presentations and training were
successful in increasing research team knowledge of data warehouses and likelihood to use this
technology, but did not result in a subsequent increase in access or training requests within the
study period. In addition, 24% of trainees completed the associated data warehouse activities to
achieve their intended outcomes within 30 days of training. The time needed for adopting the
technology, the ease of use of data warehouses, the types of support available, and the data
available within the data warehouse may all be factors influencing this completion rate.

Conclusion: The key finding of this study is that data warehouse awareness presentations and
training sessions are insufficient to result in research team adoption of the technology within a
three-month study period. Several important implications can be drawn from this finding. First,
the timeline for technology adoption requires further investigation, although it is likely longer
than 90 days. Future assessments of technology adoption should include an individual’s timeline
for pursuing the use of that technology. Second, this study provided a definition for outcome
achievement, which was completion of activities within a data warehouse needed to achieve an
intended research outcome as identified by the research team. While this definition is a good
baseline, it needs to be refined with input from research teams. Finally, this study confirmed
previous findings related to technology adoption, which indicated that time, ease of use, support,
and data availability are important factors. Additional work is needed to identify the significance
and correlation of these factors with technology adoption.
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This study provides important findings regarding attainment of technology knowledge and its
links to actual technology use, the correlation between self-reported likelihood to use and actual
technology use, the timeline of technology adoption, and foundational protocols for objective
measurement of technology use and adoption. Future research should focus on refining the
objective measurement of “outcome achievement,” understanding the timing of technology
adoption, and measuring the significance and correlation of factors influencing data warehouse
use.
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CHAPTER 1:

INTRODUCTION

In 2002, the United States (US) National Institutes of Health (NIH) announced development of
the NIH Roadmap to accelerate research progress.1 In creating this roadmap, leaders identified
three themes on which to focus national strategies regarding research acceleration: New
Pathways to Discovery, Research Teams of the Future, and Reengineering the Clinical Research
Enterprise.1,2 One of the strategies to address the final theme was the launch of the Clinical and
Translational Science Awards (CTSA) program. Announced in October 2005, the program’s
goals are to eliminate barriers between basic and clinical research, address the increasing
complexities in conducting clinical research, and create academic homes for clinical and
translational science.2

Administered by the National Center for Advancing Translational Sciences (NCATS), the CTSA
program distributes funds to a national network of more than 50 medical research institutions,
also known as “hubs,” that work together to improve the translational research process.3,4 In
fiscal year 2016, a total of more than $487 million was awarded to 57 CTSA hubs.4 With this
funding, each hub is required to achieve five goals related to translational research. One of these
goals is to “advance the use of cutting-edge informatics.”3 In addition, a high priority is the use
of information technology (IT) to integrate clinical research and clinical workflows,5 and the
NIH has called for increasing the secondary use of electronic health record (EHR) data for
clinical research purposes.6

Based on these priorities, many CTSA hubs have implemented and maintain data warehouses,
which are “’…subject-oriented, integrated, time-variant, non-volatile collection[s] of data…’
1

[that address] data management, integration, and access issues.”7 According to a 2010 CTSA
survey, 86% of respondents indicated that their organization had one or more data warehouses.8
These data warehouses combine disparate data types from a range of clinical and administrative
sources such as EHRs and registries and may include data from multiple institutions.8 The result
is a comprehensive set of records that extends beyond the data contained within a single EHR
and provides more valuable information for translational research.

1.1

Research Problem and Overall Aims

Although significant research is being conducted about and with data warehouses for current and
future clinical and translational research purposes, critical gaps exist in the literature corpus and
real-world implementation and practice. First, little is known regarding the effectiveness of
interventions in increasing researcher and research team awareness of data warehouses and their
use in clinical and translational science. Second, while CTSA hubs often provide data
warehouse training for research teams, little is known about the effectiveness of this training and
subsequent use of data warehouses. Finally, a critical gap exists in defining objective measures
for determining if research teams achieve their intended outcomes when using data warehouses.

To study these knowledge gaps and identify areas that require new solutions, this study
developed a presentation intervention to raise research team awareness of data warehouses and
assessed and measured the outcomes of this intervention. In addition, the study assessed and
measured the outcomes of existing data warehouse training. Finally, the study identified
potential factors that influence the achievement of intended outcomes when using a data
warehouse.
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1.2

Study Conceptual Frameworks

To achieve these aims, the study approach was based on the five innovation-decision stages
(knowledge, persuasion, decision, implementation, and confirmation) identified in the Diffusion
of Innovation (DOI) theory.9 In addition, the Technology Acceptance Model (TAM) and
DeLone and McLean Information Systems Success Model were used to identify critical content
for the awareness presentation intervention and existing training and to focus assessment on key
aspects influencing technology adoption and acceptance. Finally, the Bloom’s Taxonomy of
Educational Objectives was used to correctly structure assessment items for the awareness
intervention and training learning objectives. The details of these frameworks are provided in
Chapter 3: Conceptual Frameworks.

1.3

Scope and Approach

This research study was performed within the Clinical and Translational Science Institute (CTSI)
of Southeast Wisconsin in collaboration with the CTSI Biomedical Informatics (BMI)
department. The CTSI BMI department provides a Clinical Research Data Warehouse (CRDW)
that contains data from a variety of EHRs, clinical information systems, and registries, similar to
data warehouses implemented by other CTSA hubs. Subsequently, this study focused on the
CRDW and its use as representative of similar data warehouses for clinical and translational
research purposes. Data for this study was collected through assessment tools, BMI databases,
and CRDW audit trails. The research questions and hypotheses, as well as specific aspects of the
study’s methodology, design, and procedures are provided in Chapter 4: Methods.
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1.4

Significance of the Study

While funding for research has declined since 2004, the need for rapid, innovative, and
lifesaving clinical and translational research has never been greater.10 In the US population,
68% of adults age 65 or older have at least two chronic health conditions, and a third of adults
are considered obese.11 In comparison to other developed countries around the world, the US
has lower life expectancy, higher rates of mortality for ischemic heart disease, and higher rates of
adverse outcomes from diabetes.11 Finding effective diagnostic and treatment methods to
address the complex challenges in individual and population health will require a team science
approach, creating the need for multidisciplinary collaboration among practitioners and
researchers.12

Individuals trained in biomedical informatics are uniquely suited for this research approach.
Biomedical informaticists have competencies in the creation and application of models for
biomedical data, information, and knowledge.13 In addition, they are expected to understand
concepts and data that span the translational medicine spectrum (e.g., biology, clinical care,
epidemiology, and health services). Because integrating clinical and research data from diverse
data sources and numerous multidisciplinary teams will be critical for cost-effective and efficient
translational research, biomedical informatics approaches will be required “…to manage,
organize, and integrate heterogeneous data to inform decisions from bench to bedside to
community to policy.”12

Although technologies have already been implemented to support this requirement, more
information is needed to understand how these technologies are adopted and what outcomes are
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achieved when using them. By assessing and measuring the CTSI BMI CRDW adoption and
use, this study aims to provide greater understanding of data warehouse adoption and the
outcomes achieved. With this understanding, the most effective and efficient development,
implementation, and maintenance strategies can be used to increase the return on investment for
these resource-intensive data warehouse technologies. In addition, technologies can be better
designed to ensure they are meeting the needs of clinical and translational science in the 21st
century and beyond.

1.5

Summary of Remaining Chapters

This chapter provides an overview of the study aims and a summary of the research approach,
scope, and significance. Subsequent chapters provide the following information:


Chapter 2: Literature Review provides the basis for the research aims, as well as the potential
contribution of this study to the existing literature corpus.



Chapter 3: Conceptual Frameworks identifies the theoretical models used to design the study
components within this research project.



Chapter 4: Methods describes the research questions, design, hypotheses, and associated
study components; the CTSI and associated target population; and project elements such as
timeline and budget.



Chapter 5: Results provides the study findings, including the acceptance or rejection of each
of the study’s hypotheses.



Chapter 6: Discussion reflects on the findings based on the study’s research questions and
outlines future research opportunities.
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CHAPTER 2:

LITERATURE REVIEW

The focus of this research study is the use of data warehouses for clinical and translational
research. This chapter describes several areas within literature that informed this study.


Section 2.1, The National Institutes of Health (NIH), provides an overview of the NIH, its
role in the creation of the CTSA program, and the need for biomedical informatics within this
program.



Section 2.2, Use of Electronic Health Record Data for Research, describes the use of EHRs
within research, including the challenges that have led to the development and
implementation of data warehouses (integrated data repositories).



Section 2.3, Summary of Research Themes in Current Literature, summarizes the literature
relating to data warehouses and their uses for research purposes.



Section 2.4, Importance of Data Warehouses in Future Research, outlines key areas of future
research requiring the use of data warehouses and associated skills.



Section 2.5, Key Gaps Within Existing Literature, identifies the key gaps that exist within the
literature corpus related to data warehouses and their use for clinical and translational
research.

2.1

The National Institutes of Health (NIH)

In 1887, the NIH began as a one-room laboratory within the Marine Hospital Service (MHS), the
predecessor agency to the US Public Health Service (PHS).14,15 Since then, the NIH has grown
to include 27 institutes and centers, including the National Cancer Institute (NCI), the National
Library of Medicine (NLM), the National Human Genome Research Institute (NHGRI), and the
NCATS.16 With funding of more than $32 billion in fiscal year 2016, the NIH has become the
6

world’s largest funder of biomedical research, supporting more than 300,000 scientists and
technical personnel working at more than 2,500 universities, hospitals, medical schools, and
other research institutions in the US and throughout the world.17,18 Supported by this funding,
research advances have led to increased average life expectancies for Americans, reductions in
disability rates, and reductions in all-cause mortality rates, including rates due to cardiac disease,
diabetes, stroke, and cancer.2,17 Overall, NIH-supported research has been a primary source of
new discoveries, drugs, devices, and clinical procedures that have contributed to the health and
longevity of individuals and populations around the world, resulting in more than eighty Nobel
prizes.10,15 The following subsections describe the development of the NIH roadmap to
accelerate research, the subsequent creation of the CTSA program, and the need for biomedical
informatics within CTSA hubs.

2.1.1

Development of the NIH Roadmap

Supporting this type of research has not been without challenges, especially in the early 2000s.
During that time, the US faced deep federal and trade deficits, increased spending for homeland
security, and unexpected economic and financial devastation from natural disasters such as
Hurricane Katrina.2 From a population perspective, the US faced an aging population suffering
from predominantly chronic diseases, as well as emerging public health challenges in the form of
obesity and diabetes.2 Within the scientific research community, costs were rising, yet funding
was beginning to decrease after years of increases.1,2 By 2004, NIH funding reached its peak,
and then began to decline nearly 2% per year, resulting in a 13% decrease in NIH purchasing
power.10 In response to these challenges, the NIH needed to devise a strategy to improve the
return on its investment by reducing costs and refocusing the clinical research enterprise.

7

Beginning in 2002, the NIH began working on the “NIH Roadmap” with the goal of defining a
set of limited priorities that could lead to the acceleration of research across the institute
missions.1 As a national clinical research enterprise, several key challenges needed to be
addressed in this roadmap. First, research study participants would need to increase in number
and diversity (such as by gender, age, and ethnicity) to support the speed of discovery.
Encouraging public participation would require addressing concerns related to conflicts of
interest, safety, and privacy.19 Second, information systems would need to be developed and
implemented to support effective and efficient data capture, maintenance, and retrieval.
Addressing this challenge would require creation of data and exchange standards, as well as
educational programs to produce a qualified workforce in biomedical informatics.19 Third,
accelerating the rate of research requires an adequately trained workforce of many kinds of
investigators such as clinicians, basic scientists, computer programmers, and engineers who can
work together on the complex issues facing health and healthcare. Funding sources and
programs would need to be created to support the work of young researchers, as well as
incentivize multidisciplinary projects.19 Finally, overall funding (government, industry, and
foundations) would need to increase to support the identified initiatives.19

After consulting more than 300 of the nation’s biomedical leaders from academia, government
organizations, and industry regarding these challenges, three themes emerged and became the
foci for the NIH Roadmap: New Pathways to Discovery, Research Teams of the Future, and
Reengineering the Clinical Research Enterprise.1,2 The New Pathways to Discovery theme
focuses on initiatives to address the technologies and approaches necessary to understand
complex biological systems and address contemporary research issues such as building blocks
and pathways, molecular imaging, bioinformatics, computational biology, and structural
8

biology.1 The Research Teams of the Future theme focuses on the creation of new team science
organizational models that provide mechanisms for high-risk strategies, interdisciplinary
research, and public and private research partnerships.1 Finally, the Reengineering the Clinical
Research Enterprise theme focuses on creating integrated networks of academic centers and
communities to support clinical trials and research, as well as creating the training programs and
informatics infrastructure necessary to make these networks effective, efficient, and trustworthy.1

2.1.2

Creation of the CTSA Program

Once identified, these themes were translated into specific NIH awards and initiatives. In fiscal
year 2005, for example, the roadmap initiatives resulted in 345 individual awards at 133
institutions in 33 states.2 One of the initiatives related to the Reengineering the Clinical
Research Enterprise theme was the development of the CTSA program. Announced in October
2005, the program’s goals are to eliminate barriers between basic and clinical research, address
the increasing complexities in conducting clinical research, and create academic homes for
clinical and translational science.2 The program focuses on translational research, which has two
approaches. The first, known as “bench-to-bedside” research, is the translation of laboratory
discoveries to clinical practice with the end goal of new treatments that can be used clinically or
commercially.8,20 The second, known as health services research, is the translation of research
and treatments into practice, making sure that these interventions reach the patients and
populations for whom they are intended as well as using clinical practice to inform new studies.
This type of translational research looks to improve the quality of care by increasing access,
coordinating systems of care, providing information and decision support for clinicians, and
strengthening the patient-provider relationship.8,20,21 With new knowledge about disease having
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a 15- to 25-year gestation from basic discovery to clinical application and most research being
adopted by only 50% of clinicians within 17 years, the need to accelerate both forms of
translational research is critical to addressing current and future challenges in health and
healthcare.10,22

Administered by NCATS, the CTSA program distributes funds to a national network of more
than 50 medical research institutions, also known as “hubs,” that work together to improve the
translational research process.3,4 For example, in fiscal year 2016, a total of more than $487
million was awarded to 57 institutions through the CTSA program.4 With this funding, each hub
is required to achieve the following CTSA program goals:


“Train and cultivate the translational science workforce.



Engage patients and communities in every phase of the translational process.



Promote the integration of special and underserved populations in translational research
across the human lifespan.



Innovate processes to increase the quality and efficiency of translational research,
particularly multisite trials.



Advance the use of cutting-edge informatics.”3

2.1.3

Need for Biomedical Informatics within CTSA Hubs

Since the inception of the CTSA program, the NIH has recognized “… the critical need to apply
biomedical informatics theories and methods to enable the collection, exchange, management,
analysis and dissemination of multidimensional datasets and knowledge collections.”23 As
defined by the American Medical Informatics Association (AMIA), “biomedical informatics
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(BMI) is the interdisciplinary field that studies and pursues the effective uses of biomedical data,
information, and knowledge for scientific inquiry, problem solving, and decision making, driven
by efforts to improve human health.”13 Although biomedical informaticists will typically
specialize in one or more application domains such as biology (bioinformatics), clinical care
(clinical informatics), research processes (research informatics), or public health (public health
informatics), the BMI core competencies have broad applicability inside and outside of
biomedicine.24 In addition to fundamental scientific skills such as problem definition, data
analysis, solution generation and implementation, collaboration, and discussion and
dissemination of ideas, such core competencies include familiarity with biological, biomedical,
and health concepts and problems; creation and application of models for biomedical data,
information, and knowledge; knowledge of data structures, algorithms, programming,
mathematics, and statistics; and understanding and application of the fundamentals of social,
organizational, cognitive, and decision sciences.13

Proficiency in these core competencies makes biomedical informaticists uniquely suited for
translational research. Because integrating clinical and research data is critical for cost-effective
and efficient translational research, BMI approaches are required “…to manage, organize, and
integrate heterogeneous data to inform decisions from bench to bedside to community to
policy.”12 Additionally, achievement of translational innovations requires a team science
approach, creating the need for multidisciplinary teams of practitioners and researchers to
conduct studies.12 Because biomedical informaticists are expected to understand concepts that
span the translational medicine spectrum (e.g., biology, clinical care, epidemiology, and health
services), they have the ability to interact and communicate effectively with a variety of team
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members, as well as serve as translators for the entire team.12 Subsequently, BMI expertise and
resources are critical for CTSA hubs to achieve program goals.23

2.2

Use of Electronic Health Record Data for Research

For most CTSA hubs, BMI programs have focused on informatics training, database
design/hosting, data warehouses, data sharing infrastructure, and complex data analyses.23
Among these activities, a high priority is the use of IT to integrate clinical research and clinical
workflows.5 In addition, the NIH has called for increasing the secondary use of EHR data for
clinical research purposes.6 Based on these priorities, BMI programs began to focus on the use
of existing data sources, specifically EHRs, for clinical and translational research purposes. The
following subsections describe the impact of government incentives on the rate of EHR adoption,
the challenges in using EHR systems for research purposes, and the creation of data warehouses
to address these challenges.

2.2.1

Impact of Government Incentives on EHR Adoption

Although EHRs contain a wide array of clinical data that have tremendous potential for
comparative effectiveness and outcomes research, direct use of this data has proven
problematic.25 One initial challenge was the low adoption rate of health information technology
(HIT) and EHRs. In 2008 (just two years after the first CTSA hubs received funding), less than
10% of non-federal acute care hospitals had adopted basic EHRs that allowed entry and retrieval
of patient demographics; problem lists; medication lists; medication orders; discharge
summaries; and lab, radiology, and diagnostic test results.26 While researchers estimated that
adopting EHRs could result in saving more than $77 billion annually, the adoption of HIT was
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modest compared to other industries and showed little sign of increasing significantly.27
Recognizing the need to reengineer the way healthcare data are collected, stored, and used, the
US government passed the Health Information Technology for Economic and Clinical Health
(HITECH) Act in 2009.28 Part of the American Recovery and Reinvestment Act (ARRA) of
2009, the HITECH Act set aside $29 billion over ten years to support the adoption of EHRs.28 A
key component of this legislation was incentive payments for eligible professionals and hospitals
that demonstrated meaningful use of these EHRs.29 By 2015, these incentives resulted in more
than $20.9 billion in payments to professionals and hospitals.30 In addition, 96% of non-federal
acute care hospitals possessed EHR technology, with almost 84% of these hospitals having
implemented basic EHR functionality.26

2.2.2

Challenges in Using EHR Systems for Research Purposes

While the HITECH Act has increased the adoption of EHRs, EHR systems and underlying
databases are not structured for research purposes, which poses inherent challenges when
attempting to use EHR systems for capturing, storing, and retrieving research data. While some
organizations have been successful in configuring EHRs for both clinical and research
purposes,31 most have struggled to overcome basic conflicts between the information and
workflow needs of clinicians and researchers.25

One fundamental issue is that EHR systems are optimized to quickly store and retrieve
information based on a single patient, while research requires querying data over multiple
patients.32 Within some EHR systems, only limited functions may be available to construct
multi-patient queries and/or these queries may require significant time to complete.
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Additionally, EHR system contracts may create problematic organizational boundaries.
Generally, the purchase, implementation, and maintenance of an EHR system is governed by a
contract between the EHR vendor and the purchaser. Contractual terms may limit the number of
licenses that can be used to access the EHR and/or the organizations that may enter data within
the system. The result is an EHR system that includes information for a single healthcare
organization, while research may require data from multiple institutions.25

A third issue is that EHR systems are designed to capture unstructured, narrative data that
involve no or a minimally specified data model. While EHR systems may include some data
rules and validation (such as not allowing entry of birthdates with a year 1800 or limiting entries
to a defined list of options), a significant amount of EHR data cannot be validated by the system,
nor do most systems provide a significant number of features for data validation and analysis. In
contrast, research databases often involve well-defined and structured data in discrete fields to
allow the system-supported validations and analyses required to answer specific research
questions.25

Finally, most EHR systems capture data such that clinicians are not required to clean or
transform data prior to its use in clinical contexts. As a result, most EHR systems lack the
necessary functions and features to perform the type of data cleaning and/or transformation
required for research purposes. In addition, even if these features were provided within an EHR
system, performing data cleaning and/or transformation within the primary clinical database
could prove harmful to patient care if done incorrectly.32
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In an attempt to address these challenges, EHR system vendors have developed functions and
features to allow organizations to share their EHR systems with partners (such as independent
physician groups) and to extract EHR data into databases specifically for reporting purposes.
Unfortunately, these advancements do not address the lack of an underlying data model in the
originating system, nor the need for competing health systems to participate in the same research
project. As a result, CTSA hubs have investigated alternative approaches for using EHR data
within translational research.

2.2.3

Creation of Data Warehouses for Research

In response to these challenges, many CTSA hubs have implemented and maintain data
warehouses (also known as integrated data repositories), which are “’…subject-oriented,
integrated, time-variant, non-volatile collection[s] of data…’ [that address] data management,
integration, and access issues.”7 For example, according to a 2010 CTSA survey, 86% of
respondents indicated that their organizations had one or more data warehouses.8 These data
warehouses combine disparate data types from a range of clinical and administrative sources
such as EHRs and registries and may include data from multiple institutions.8 Additionally,
instead of being built to only support one workflow (such as clinical care), data warehouses
typically support a range of heterogeneous users including researchers, clinicians, and
administrators.8 From a data quality perspective, data warehouses can store metadata from each
of the originating systems that explain the context in which the data were captured and their
meaning, which increases the likelihood of correctly translating the data. Because these data
warehouses also contain data from multiple sources, researchers can access more complete
information for an individual patient (such as having access to records from multiple hospitals
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for a single patient) and/or link clinical information with financial, utilization, and quality data to
verify consistency of records (such as ensuring that gynecological exams were only conducted
on biologically female patients).33 The result is a more comprehensive set of data that extends
beyond the contents of a single EHR system and provides more valuable information for
translational research.

2.3

Summary of Research Themes in Current Literature

The creation of data warehouses for clinical and translational research has resulted in studies
related to their development and implementation. In addition, clinical researchers have begun to
publish studies based on the use of EHR and other data from these data warehouses. Finally,
another category of literature relates to improving data warehouses for research purposes. The
following subsections provide examples of these studies and summarize the key findings.

2.3.1

Data Warehouse Development and Implementation

Literature focusing on data warehouse development and implementation provides insight into the
benefits and challenges of implementing these platforms. Common themes include the creation
of a common data model and/or mapping that can be used to transform data from local systems
into the data warehouse; technical architectures that can be scaled to integrate data from a variety
of sources; and the need to protect patient privacy while reducing regulatory burden. Below are
several examples of data warehouse projects described in the literature that represent these
themes.
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The Observational Health Data Sciences and Informatics (OHDSI) program is “an international
collaborative whose goal is to create and apply open-source data analytic solutions to a large
network of health databases to improve human health and well-being.”34 Coordinated through a
center housed at Columbia University, the OHDSI team of academics, industry scientists, health
care providers, and regulators have developed a common data model that can be used to
transform databases into a common format that can be centralized into a single data warehouse
for research purposes.34,35 Once transformed into this structure, researchers can apply the open
source analytic tools for data exploration (ATLAS), data quality assessment (ACHILLES),
feasibility assessment (CALYPSO), and drug exposure visualization (DRUG EXPOSURE
EXPLORER) that have been developed by OHDSI.34,35 Additionally, researchers can join the
OHDSI research network and collaborate on research projects.35 Continued development of this
platform will support observational studies that inform clinical practice using the unprecedented
amount of patient data currently available.34

European researchers have developed the Electronic Health Records for Clinical Research
(EHR4CR) project, which is “…an innovative platform capable of transforming conventional
clinical research processes by enhancing protocol feasibility assessment, patient identification for
recruitment, and clinical data exchange.”36 Funded by the European Commission and the
European Federation of Pharmaceutical Industries and Associations (EFPIA), the EHR4CR
project involves 34 academic and private partners working together with the goal of developing
adaptable, reusable, and scalable solutions for reusing EHR data for research purposes.36,37 The
platform is based on a Service Oriented Architecture (SOA) that allows service providers and
consumers to dynamically connect to the platform through clearly defined interfaces.37 Data
from clinical data warehouses or EHRs at local sites are interfaced and mapped to the EHR4CR
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database and then provided through different services to the end user.37 These services are
focused on particular use cases such as querying of eligibility criteria, recruiting patients, and
mapping terminology.37 Security is maintained through implementation of standards such as
SOAP (web service interactions), WS-Security (secure messaging), WS-Trust (relationship
brokering), and SAML (end user authentication).37 As a result of this work, the European
Institute for Innovation through Health Data (i~HD) has been formed to guide and catalyze
“…the best, most efficient and trustworthy uses of health data and interoperability for optimizing
health and knowledge discovery.”38

The Oncoshare project was founded in 2008 as a collaboration among Stanford University, the
Palo Alto Medical Foundation, and the Cancer Prevention Institute of California with the goal of
developing a shared database for translational research and outcomes analysis specifically for
women treated for breast cancer.39,40 This shared data warehouse integrates data from registries,
EHRs, genomic sequencing laboratories, and patients, providing the necessary breadth and depth
to identify care pathways that provide the best outcomes for patients.39,40 To create this
integration, records that meet the inclusion criteria are transformed into a standard data model
and then aggregated into a shared, anonymized data warehouse.39 From this data warehouse,
researchers can create data marts that are specific to their particular research questions.39 These
data marts contain a subset of data from the data warehouse and are focused on a specific
research question or subject area.41 The Oncoshare project has resulted in more than 20
publications and presentations, and ongoing research continues with funding from the NCI and
the NIH CTSA program, among others.40
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In 2008, the NIH Clinical Center established a data warehouse known as the Biomedical
Translational Research Information System (BTRIS), which contains data on over 500,000
research subjects.42 While researchers can extract both de-identified and identified data from the
BTRIS, practical and administrative challenges exist related to patient privacy regulations.42
Because one approach to reducing this regulation is to use data from deceased patients,
researchers from the NIH Clinical Center used BTRIS to identify deceased patients and extract
them into a separate data warehouse.42 While continued work is needed to clarify the regulatory
guidance for de-identifying decedent records and to determine the effect of bias that may exist
(such as having a proportionately larger number of older, sicker patients than the BTRIS), a data
warehouse consisting of deceased patient records could prove an important tool to reduce
regulatory burden when accessing data for research purposes.42

2.3.2

Use of Data from EHRs and Data Warehouses

Literature also exists that describes the results of using data from EHRs and data warehouses for
clinical and translational research purposes. One category of literature addresses the ability to
more effectively and efficiently perform research tasks such as cohort identification and
feasibility assessment using data warehouses when compared to traditional methods. A second
category includes literature that attempts to replicate clinical research through use of a data
warehouse. While these studies have identified efficiency gains and some ability to replicate
results, caution is advised when considering a complete replacement of traditional methods with
data warehouse supported methods. Below are several examples from the literature of these
types of research studies.
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Based on EHR data, Mayo Clinic researchers compared two methods for prospective recruitment
of patients with heart failure – one using natural language processing (NLP) and one using
predictive modeling – to traditional methods that rely on coding information.43 Reliance on
coding information is problematic for some diseases, such as heart failure, which cannot be
diagnosed with a single test and may have a variety of symptoms due to its syndromic nature.43
In addition, coding is a manual process that introduces delays in identifying patients for
recruitment. To find a more effective and efficient process for prospective recruitment,
researchers developed algorithms for these two approaches and applied them to EHR clinical
notes. They found that the NLP algorithm identified all the heart failure patients that could be
identified by the traditional coding approach, but also identified additional cases that the
traditional approach had not identified, which could be helpful as a screening mechanism for
observational studies.43 The predictive modeling algorithm had a positive predictive value of
82%, which indicates a high likelihood of identifying patients that truly have heart failure,
making this method a good screening mechanism for clinical trial inclusion and exclusion
criteria.43 A key benefit of using these screening mechanisms is that they rely on clinical notes,
which are typically available more quickly than traditional coding; thus, researchers can identify
patients more quickly for participation in research studies.43

Using the EHR4CR platform, researchers performed a cost-benefit analysis (CBA) to assess the
value of the EHR4CR compared to current research processes for hypothetical Phase II and
Phase III oncology trials.36 Three scenarios were analyzed: protocol feasibility assessment,
patient identification for recruitment, and clinical study execution.36 In performing this analysis,
researchers found that using EHR4CR would translate into faster time to market (20% reduction
in average cycle time) and reduced resources and costs (50% reduction in person time and
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costs).36 Using the EHR4CR platform, these benefits were achieved through reducing the efforts
required for refinement of inclusion and exclusion criteria, accelerating patient recruitment, and
optimizing clinical trial execution.36

Researchers in the United Kingdom (UK) used a comprehensive longitudinal electronic clinical
database, the UK General Practice Research Database (GPRD), to replicate a set of six
previously completed randomized controlled trials related to cardiovascular drug treatments.44
The GPRD is a data warehouse that contains over eight million patient records from a
representative sample of 5.7% of the UK population from 1990-2000.44 While some limitations
were identified, such as missing or limited lab results, vitals, and history, the results of this work
suggested that “…observational studies using databases might produce valid results concerning
the efficacy of cardiovascular drug treatments.”44

2.3.3

Improvement of Data Warehouses for Research Purposes

Although literature contains examples of the benefits of using data warehouses for clinical and
translational studies, considerable challenges exist before data warehouses are optimized for
research purposes. Broadly, these challenges involve data quality, data models and standards,
data structure, and ethical and legal considerations. Below is a summary of these challenges and
the work being done to improve data warehouses.

Data quality is one of the most significant challenges in the use of data warehouses for research
purposes, in part because the concept of data quality is multi-dimensional and lacks a commonly
accepted definition.45–48 Within the literature, the concepts of accuracy and completeness are
most often used in data quality descriptions.45–47,49–55 Accuracy, which can be defined as the
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extent to which data conform to the truth, often relies on correct and careful documentation,
which can be challenging in a busy patient care setting.45,55 The result can be wrong diagnoses
on a problem list, inclusion of documentation for two patients within the same record, and
implausible documentation of services (such as gynecological services for biologically male
patients).46,55 The definition and measurement of data quality concepts, though, can be context
dependent, meaning that data considered high quality for one use may be considered poor quality
for another use.48 For example, completeness in a clinical setting may be defined as
documenting all of the observations from a patient encounter, while completeness when reusing
this same data for research purposes may be defined as containing all the data elements
necessary for the research study.6,49,55–58 Without a standard definition of data quality, efforts to
improve data warehouses will produce marginal results, if any. In addition, perceptions of poor
data quality could prove to be a significant barrier in the adoption of data warehouses in clinical
and translational research. To address this challenge, current research focuses on identifying
frameworks and ontologies for data quality45–47,52 and assessing data quality using these
tools.56,57,59

Additionally, the lack of a single, accepted data model for clinical and translational research has
hampered interoperability across institutions and countries.60 As a simple example, a laboratory
test such a comprehensive blood count (CBC) can be coded as a CBC in one system and code
1568 in another system. When attempting to integrate laboratory tests into a single data
warehouse, they must to be mapped to a single, common concept. Without this mapping, a
researcher would need to know to use CBC and 1568 as codes to extract CBC results, which is
an unrealistic expectation and likely to cause data to be missing from the data extraction. To
address this challenge, various international certification and standards bodies continue to pursue
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the goal of creating the necessary models and standards. Once identified, significant work will
be required to implement these standards in EHRs, registries, and other data sources so that the
overhead of transforming and mapping these data into data warehouses can be reduced.60

From a data structure perspective, a significant portion of data from clinical sources is
maintained within unstructured narratives, such as admission notes, treatment plans, and patient
summaries.60 While abundantly available, this type of data is computationally the most difficult
to analyze due to its heterogeneous nature; lack of conformity with grammar and sentence
structures; and use of abbreviations, acronyms, and idiosyncratic language.60 Additionally,
information may be duplicated within the data structure, making it difficult to determine if these
are new findings or a restatement of existing findings.59 For example, a clinical note may
include a statement of a concerning trend in high blood pressure readings that is already captured
within the vitals data fields as discrete data. While the discrete data may be easier to manage
computationally, the clinical note may provide the most relevant information for a particular
research study. To address this challenge, current research focuses on optimizing NLP
algorithms for automated coding of this data into more discrete forms and configuring EHRs
such that data can be used for clinical and research purposes.31,43

Legally and ethically, organizations that capture, store, and retrieve patient information have a
duty to ensure the privacy of this data, a task that is particularly challenging in the age of
numerous security breaches to IT systems. To overcome this challenge, de-identification is often
used within data warehouses, but the lack of identifiers can reduce the value of the data for
research purposes.60 Additionally, researchers need to ensure appropriate consent was obtained
for the data included within the warehouse, which can create a significant administrative burden
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and potential bias in the patient population included.60 Without this consent, public trust in the
research community can erode and this, in turn, can hinder public good.61 To encourage
participation in studies, researchers must have a trustworthy process for obtaining consent and
maintaining privacy. To address these challenges, researchers are evaluating the use of data
from deceased patients as a potential alternative.42 In addition, the 21st Century Cures Act
includes provisions to improve privacy protections for research volunteers.62

2.4

Importance of Data Warehouses in Future Research

As the quality of data warehouses continues to improve based on these studies, competency in
using data warehouses will be a critical skill for research teams participating in clinical and
translational research. Future research in genomics, precision medicine, and big data analytics
will require use of large datasets containing diverse data from a variety of sources. The
following subsections describe the promise of future research in these areas, the role of data
warehouses and large datasets within these research areas, and the need for research teams to
demonstrate the necessary skills for taking advantage of these resources.

2.4.1

Genomics

From a classical Mendelian perspective, organisms contain genes that are inherited, and these
genes define a variety of observable traits depending on gene dominance.63 The goals of the
human genome project are to identify 100,000 different genes in humans and understand their
expression and function.63 Researchers involved in this project and related research “…study
genes, their interactions, their mutations, and the relationships they reveal between normal
function and disease.”63 To achieve this understanding, research teams need genomic data
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(typically, genome sequences), as well as phenotypic (clinical) data for individual patients and
populations.64 A key challenge is the development of a system to house these two distinctly
different types of data.

While effectively integrating genomic data into EHRs remains a goal for vendors and health care
systems, one of the key existing features of data warehouses is the ability to integrate data from a
variety of sources. As a result, a successful data warehouse implementation can be seen as a
precondition for integrating clinical and genomics data.65 To drive the development of more
accurate classifications of diseases and to enhance diagnosis and treatment methods, research
teams will need “a data network that integrates research data on the molecular makeup of
diseases with clinical data on individual patients….”65 Such a data warehouse will need to
include appropriate storage of this data; a framework that enables scientists and researchers to
explore the data and generate hypotheses; and information from other databases and data sources
for cross-referencing.65

Effective use of this data warehouse will require “…better integration of genomics and
biomedical informatics into curricula for clinical researchers and providers.”63 Researchers and
clinicians will need to participate in the development of standards and models for capturing and
storing this information, as well as serve as advocates in debates related to the perplexing ethical,
social, and economics issues that will occur when this data is integrated into a single platform.63
Active and informed participation will require experience with capturing, storing, and retrieving
data from a data warehouse to effectively represent the benefits and challenges of using such a
technology.
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2.4.2

Precision Medicine

In his January 2015 State of the Union Address, President Barack Obama announced the
Precision Medicine Initiative (PMI), which is meant to bring together clinical, genomic,
environmental, lifestyle, and other related data to provide a comprehensive view of a patient’s
state over time and customize disease prevention, detection, and treatment based on the
individual patient.66–68 While individual variability (such as blood type) has been considered
within some medical treatments, this initiative calls for a broad, evidence-based approach using
innovative tools (such as mobile health technologies), large-scale biologic databases (such as the
human genome sequence), powerful patient characterization methods (such as proteomics,
metabolomics, and genomics), and computational tools for analyzing large sets of data to
customize treatment and prevention and improve the overall effectiveness and quality of patient
care.67,68

In 2016, the 21st Century Cures Act was passed, which provides funding for PMI-related
initiatives, among other initiatives.62,69 Worth $4.8 billion over ten years (starting in fiscal year
2017), this funding will provide the NIH “…with critical tools and resources to advance
biomedical research across the spectrum from basic, curiosity-driven studies to advanced clinical
trials of promising new therapies.”62,69 Initiatives funded by this Act are meant to reduce
administrative burdens that slow the progress of science, enhance data sharing and privacy
protections for study participants, improve support for the next generation of biomedical
researchers, and ensure the inclusion of diverse populations in clinical research.62,69
Additionally, support is provided for four highly innovative scientific initiatives: the All of Us
Research Program, the Brain Research through Advancing Innovative Neurotechnologies
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(BRAIN) Initiative, the Cancer MoonshotSM, and the Regenerative Medicine Innovation
Project.62

The All of Us Research Program, formerly known as the PMI Cohort Program, is a longitudinal
cohort study meant to involve one million or more Americans who volunteer to provide biologic
specimens (e.g., cell populations, proteins, and genome sequences); clinical data from EHRs; and
lifestyle and behavioral information.67–69 This information will be used to create a
“..transformative research infrastructure that will enable and simplify research across all
diseases.”67,69

The goal of the BRAIN Initiative is to understand how the brain functions, which will inform
efforts to transform the ways in which neurological and mental disorders are diagnosed and
treated.62 The initiative will focus on building technology and knowledge across disciplines to
understand how circuits in the brain function in real time and what goes wrong when disease
occurs.69

The Cancer MoonshotSM will accelerate cancer research to improve prevention, detection, and
treatment.70 The goal is “…to double the rate of progress in the fight against cancer, making
more therapies available to patients, while also improving [the] ability to detect and prevent
cancer.”69

Finally, the Regenerative Medicine Innovation Project is coordinated through the NIH and the
Food and Drug Administration (FDA) and supports clinical research using adult stem cells to
further the field of regenerative medicine.62 Regenerative medicine is a field of science focusing
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on the use of stem cells and other technologies to repair or replace damaged cells, tissues, or
organs.71

All of these initiatives will require the collection, storage, and retrieval of multi-parametric data
from a variety of sources.72 Dedicated efforts will be required to integrate the multidimensional
data from EHRs, large-scale genomic-wide data, and information from mobile health
technologies into a single data warehouse to support the analytic and bioinformatics needs of
clinicians and reseachers.33 Recently, to achieve this goal, the National Academy of Sciences
(NAS) has called “…for the development of an information commons (IC) that amasses medical,
molecular, social, environmental, and health outcomes data for large numbers of individual
patients.”73 Effective use of such an IC or data warehouse will require changes to the training
and education models for clinicians and researchers to include competencies related to
quantitative reasoning, ability to access just-in-time information, and practice integrating
multiple parameters for a holistic view of the patient and/or disease.66,68,72

2.4.3

Big Data and Analytics

Big data refers to complex datasets that challenge traditional data management systems due to
the high volume of data, the diversity of the data within the dataset, and the rapid rate at which
the data changes.74–76 Within healthcare, the adoption of EHR systems, digitization of medical
images and videos, as well as other related information has resulted in an estimated 150 exabytes
(150 billion gigabytes) of data in the US healthcare system by 2011.77 Should current growth
rates continue, big data in healthcare will reach zettabytes (1021 gigabytes) or yottabytes (1024
gigabytes).

28

To effectively gain information from this data, scientists apply analytics methods. These
methods include “…the use of mathematical and algorithmic processing of data resources, as
well as techniques such as text mining and natural language processing, and visual analytics to
generate descriptive, predictive, and prescriptive models to analyze and derive insight from
data.”75 Application of these methods represents a significant opportunity for health care
delivery systems, researchers, and clinicians. Currently, clinical operations are estimated to
include $165 billion in waste, which could be reduced by applying big data analytics to
determine the most clinically relevant and cost-effective ways to diagnose and treat patients.77
Additionally, health systems could use analytics to identify the estimated 5% of patients that
account for 50% of all US health care spending and determine interventions to reduce these costs
while maintaining the quality of care.76 Research and development is estimated to include $108
billion in waste that could be reduced by using predictive modeling to produce leaner, faster, and
more targeted research for drugs and devices, as well as improve design of clinical trials.77
Application of these methods will also be required to effectively use the data gathered by the
initiatives identified within the 21st Century Cures Act.69,74 Finally, clinicians need efficient and
effective ways to apply the latest evidence in their practices, and big data analytics can be used to
better predict disease for and match treatments to individual patients.77 From a public health
perspective, these methods are already being applied by the Centers for Disease Control and
Prevention (CDC) to inform clinicians about the spread of influenza.74

To participate in the use of big data analytics, research teams will need to be versed in
informatics, as well as their chosen disciplines.75,78 Using technologies like data warehouses can
provide valuable experiences in applying informatics concepts to their existing research interests.
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Additionally, experience leveraging this technology can improve the effectiveness and efficiency
with which technologies are adopted within research programs.75

2.5

Key Gaps Within Existing Literature

Although significant research is being conducted about and with data warehouses for current and
future clinical and translational science purposes, critical gaps exist within the literature corpus.

First, little is known regarding interventions for increasing researcher and research team
awareness of data warehouses and their use in clinical and translational science. For example, is
a presentation regarding basic data warehouse functions and processes adequate to raise
awareness or is a more significant intervention required? Without appropriate interventions, a
generation of research teams may be unaware of the data warehouses available to them, resulting
in ineffective and inefficient research processes as well as a lack of experience with the
necessary informatics methods to face future research challenges.

Second, while CTSA hubs often provide data warehouse training for research teams, little is
known about the outcomes of this training. For example, at the end of training, can research
team members demonstrate accurate knowledge regarding the data warehouses available to
them? Can trainees perform activities within the data warehouses that support their intended
study outcomes? Without assessment of these activities, CTSA hubs may be investing
significant time and money into training programs that are not achieving their intended learning
objectives.
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Finally, a critical gap exists in defining objective measures for determining if research teams
perform the necessary data warehouse activities to achieve their intended research outcomes.
Without this information, the NIH and CTSA hubs are unable to determine if a return on
investment is occurring for the significant time and resources involved in implementing and
maintaining data warehouses.

As a result, critical needs exist to identify interventions that increase research team awareness of
data warehouses, to assess outcomes of data warehouse training, and to define objective
measures for determining if research teams perform the necessary data warehouse activities to
achieve their intended research outcomes.
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CHAPTER 3:

CONCEPTUAL FRAMEWORKS

To address the critical needs identified in the previous chapter, this study includes a presentation
intervention to raise researcher awareness of data warehouses, assessments of the awareness
intervention and existing data warehouse training, and definition and use of objective measures
for data warehouse activities related to research outcome achievement. The design of these
study components is based on four conceptual frameworks related to adoption of technology and
assessment of learning objectives: Diffusion of Innovation theory, Technology Acceptance
Model, DeLone and McLean Information Systems Success Model, and Bloom’s Taxonomy of
Educational Objectives. Because these frameworks have been applied in a variety of contexts
and have proven to be reliable and robust, they provide a solid theoretical foundation for this
study. This chapter provides a summary of these frameworks, as well as examples of their
applications in healthcare environments and/or with data warehouse implementation and use.

3.1

Technology Adoption Models

One of the key research areas within information systems is understanding how and why
individuals adopt new information technologies.79 Typically, this research focuses in one of
three areas: implementation success at an organizational level, individual acceptance, or tasktechnology fit.79 While many theories and models have been proposed based on these areas,
several have been widely accepted and researched for various industries, contexts, and systems:
Diffusion of Innovation theory, Technology Acceptance Model, and DeLone and McLean
Information Systems Success Model. This section will describe the theoretical basis for each
these models and provide the key findings in studies that apply them.
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3.1.1

Diffusion of Innovation (DOI) Theory

Created by Everett M. Rogers in 1962, the DOI theory is the most widely used theoretical basis
for studying technology adoption, which is defined as “…a decision to make full use of an
innovation as the best course of action available.”9,80 According to Rogers, “diffusion is the
process in which an innovation is communicated through certain channels over time among the
members of a social system.”9 Based on this definition, DOI has four main elements: the
innovation, communication channels, time, and a social system. An innovation is an idea,
practice, or object that is perceived to be new by the individual.9 A communication channel is
the means used to share messages from one individual to another such as mass media and
interpersonal channels.9 Time is defined in three ways: time from awareness to adoption or
rejection, time to accept an innovation relative to other individuals within the social system, and
the rate of innovation adoption.9 Finally, a social system is the interrelated individuals, groups,
or organizations that engage in joint problem solving to accomplish a common goal.9

Using this definition as a basis, Rogers identified a five stage innovation-decision process, which
is “…the process through which an individual…[passes] from gaining initial knowledge of an
innovation, to forming an attitude toward the innovation, to making a decision to adopt or reject,
to implementing new ideas, and to confirming this decision.”9 The following table summarizes
these stages.9
Table 1.

Stages within the Innovation-decision Process

Stage

Description

Knowledge

Individual is made aware of an innovation’s existence and gains
understanding of how it functions

Persuasion

Individual forms an attitude (favorable or unfavorable) towards the
innovation
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Stage

Description

Decision

Individual engages in activities that lead to a decision (adoption or
rejection)

Implementation

Individual puts the innovation into use

Confirmation

Individual seeks reinforcement for his/her decision and may change
this decision if exposed to conflicting messages about the innovation

Within the knowledge stage, individuals may either passively receive knowledge (such as being
exposed to innovation information during a department meeting) or actively seek knowledge
based on an identified need (such as wanting to gain access to health care data and investigating
potential data sources).9 This first exposure to innovation is known as awareness-knowledge.9
Based on this exposure, an individual may seek out how-to knowledge (information about using
an innovation properly) and principles-knowledge (information about how the innovation
works).9 While those looking to influence innovation adoption often focus on awareness, they
may be more effective by also focusing on how-to knowledge delivery.9

While the knowledge stage is mostly cognitive, the persuasion stage is more about feelings
toward the innovation, which lead to the formation of attitude.9 Attitude is defined as “…a
relatively enduring organization of an individual’s beliefs about an object that predisposes his or
her actions.”9 In forming this attitude, individuals will actively seek out information about the
innovation, determine the credibility of the messages received about the innovation, and interpret
the information that is received, all with the goal of reducing the uncertainty that is inherent in
adopting innovations.9 Often, individuals will also mentally apply the innovation to their current
or future situations as a way to further reduce their uncertainty.9
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Based on the attitude developed in the persuasion stage, the individual will decide to adopt or
reject the innovation. To cope with uncertainty, some individuals may try out the innovation on
a small-scale basis, and those who perform this trial will often move toward an adoption
decision.9 Other individuals may look to a peer to use the innovation before adopting the
innovation themselves or to demonstrations of the innovation that align with their needs.9

If an adoption decision is made, the next stage is implementation, where the individual puts the
innovation to use. To this point, the process has been a mental exercise, but implementation
involves true behavior change.9 At this stage, uncertainty exists, particularly in understanding
where the innovation can be obtained, how it is used, and how problems can be solved, so
support is needed to help reduce this uncertainty.9

Finally, as individuals use an innovation, they may decide to continue or discontinue its use
based on their experiences and/or messages received regarding the innovation during the
confirmation stage.9 Typically, decisions to discontinue use of an innovation fall into one of two
categories: replacement or disenchantment.9 Replacement discontinuance occurs when an
individual rejects an innovation in order to adopt a better innovation (such as upgrading from the
current iPhone version to a new iPhone version).9 Disenchantment discontinuance occurs when
an individual rejects an innovation due to dissatisfaction with its performance, which may be
caused by lack of compatibility between the innovation and individual need or misuse of the
innovation.9
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The rate of adoption, measured by the number of individuals who use an innovation in a
specified period, can vary significantly.9 Although the communication channel and social
system influence this rate, the majority of this variance can be explained by five attributes of an
innovation: relative advantage, compatibility, complexity, trialability, and observability.9 The
following table summarizes these attributes.9
Table 2.

Attributes of Innovation

Attribute

Description

Relative advantage

The degree to which an innovation is perceived as being better than
the innovation it supersedes

Compatibility

The degree to which an innovation is consistent with an individual’s
existing values, past experiences, and needs

Complexity

The degree to which an innovation is perceived as difficult to
understand and use

Trialability

The degree to which an innovation may be used on a limited trial
basis

Observability

The degree to which the results of the innovation are visible to
others

Within healthcare settings, the DOI theory stages and attributes of innovations have been applied
in a variety of contexts such as adoption of integrated care pathways (plans of patient care for
specific diagnoses or interventions), telemedicine, EHRs, and health care delivery models.81,82 In
the majority of cases, the DOI theory has proven to be a solid theoretical foundation with
consistent empirical support that can be used to explain an individual’s adoption process,
especially in the knowledge, persuasion, and decision stages.80 In all contexts, the main criticism
of this theory is the focus on individual versus organization adoption of innovation.80
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3.1.2

Technology Acceptance Model (TAM)

Similar to the concept of adoption, technology acceptance is an individual’s psychological state
regarding his/her voluntary or intended use of a technology, and studies have found that this
intention to use a technology can be used to predict actual use of that technology.83–85 The TAM
is an adaptation of the Theory of Reasoned Action (TRA) specifically for modeling and
predicting user acceptance of information systems.86 The TRA states that an individual’s
intention to perform a behavior is based on his/her attitude toward the behavior and his/her
perception that important individuals to him/her believe the behavior should or should not be
performed (known as subjective norm).83 Although based on the TRA, the TAM does not
include the concept of subjective norm and identifies two particular beliefs, perceived usefulness
and perceived ease of use, that are relevant to acceptance of technology.83 The following table
summarizes the concepts used within the TAM.
Table 3.

Concepts within the Technology Acceptance Model

Concept
External variables

Acronym
(none)

Definition
External factors such as human, social, and
system factors83,87

Perceived usefulness

PU

An individual’s perception that using a
particular technology will enhance his or her
job performance79,83,86

Perceived ease of use

PEOU

Attitude toward using
technology

A

An individual’s feelings (positive or negative
about performing a behavior79,83,86

Behavioral intention

BI

Measure of the strength of an individual’s
intention to perform a specified behavior83

An individual’s expectation that using the
system will be free of effort79,83,86
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According to the TAM, these beliefs determine an individual’s attitude toward the technology.
In addition, attitude and perceived usefulness determine behavioral intention. Finally, these
beliefs are influenced by external variables such as available training, organizational support, and
system features.83,87 These relationships are shown in the following figure.
Figure 1.

Technology Acceptance Model

Adapted from Davis et al., 1989.

The TAM has been well tested in a variety of business and healthcare contexts and has proven to
be reliable and robust in predicting technology acceptance.88,89 The following table provides a
summary of several studies and their results within healthcare contexts.
Table 4.

Results of Using the Technology Acceptance Model in Healthcare Contexts

Population

Technology

Prediction of BI

Physicians

Telemedicine

42-44% of observed
variance in BI85,90

Physicians

Internet-based health
applications

59% of observed variance
in BI88

Residents and physicians

Personal digital assistants
(PDAs)

57% of observed variance
in BI91

Physicians, nurses, and medical
technicians in Taiwan

Mobile health

70% of observed variance
in BI92

Medical personnel in Taiwan

Adverse event reporting
system

59% of observed variance
in BI93
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Population

Technology

Prediction of BI

Hospital personnel in Greece

Hospital information systems 87% of observed variance
in BI94

Nurses

Remote intensive care unit
monitoring (eICU)

58% of observed variance
in BI95

Physicians

EHRs

44-56% of observed
variance in BI96,97

Within these studies, the typical approach is to survey or interview a sample population using a
series of items designed to assess the concepts within the model. Each concept is assessed using
multiple items that include a mix of positive and negative statements. For example, some ease of
use items are “Learning to operate [technology] is easy for me” and “I believe that it is easy to
get a [technology] to do what I want it to do.”98,99 Responses to these items are measured using a
five- or seven-point Likert-type scale with values ranging from strongly agree to strongly
disagree.92,99 Likert responses are then converted to numeric equivalents, and data analysis is
typically performed using structured equation modeling (SEM) to determine the effect of each of
the concepts.

Based on this analysis, the majority of studies using the TAM have found perceived usefulness to
be a strong determinant of intention to use.83,85,95–97,99–102,86–89,91–94 In comparison, studies have
shown mixed results for perceived ease of use, with some studies indicating a strong link
between PEOU and intention to use83,86,92–97,101,102 and others indicating PEOU is not a
significant determinant.85,87–89,91,99,100 Generally, perceived ease of use was identified as a
secondary determinant to perceived usefulness.83 As stated by Davis et. al, “users may be
willing to tolerate a difficult interface in order to access functionality that is very important,
while no amount of ease of use will be able to compensate for a system that doesn’t do a useful
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task.”83 Interestingly, studies involving physicians were more likely to find that PEOU was not a
significant determinant, which researchers postulate is due to a higher level of competence,
intellectual and cognitive capacity, adaptability to technology, and operational support for
physicians in comparison to other populations studied.85,89,90,99

Several themes emerged from these studies. One common theme was the need for users to
recognize the technology as compatible with their work tasks and job performance in order to
perceive the technology as useful.84,92,103 Training was also a recurrent theme, indicating that
training interventions focusing on the benefits of the technology as well as including content
regarding real-life scenarios influenced perceived usefulness and attitude.87,91,92,94,96 Also
identified was the need for appropriate ongoing support for the technology once training was
complete.87,92,102 Another theme was the need to demonstrate the effectiveness of a technology,
particularly in comparison to the status quo, to improve attitude and perceived usefulness of a
technology.84,91 Finally, although intention has been shown to be a good predictor of actual use
of a technology, researchers identified the need to include objective measures of actual use
whenever possible.86,104

3.1.3

DeLone and McLean Information Systems Success Model

One of the first models used to measure successful implementation of information systems was
created by DeLone and McLean in 1992. Known as the DeLone and McLean Information
Systems (D&M IS) Success Model, the model is an attempt to define a dependent variable for
information system (IS) research, as the evaluation of practices, policies, and procedures requires
an established dependent variable.105 The original model identified six interrelated dimensions
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as categories of IS success.105,106 In 2003, ten years after the initial publication of this model,
DeLone and McLean updated the model based on the research studies conducted during that time
period. At that time, two extensions of the model were identified: the addition of service quality
and the introduction of net benefits to address all the impacts (including individual and
organization) of a system.106 The following table summarizes these dimensions and typical
measurements used.
Table 5.

D&M IS Success Model Dimensions

Dimension

Model
Year

Description

Example Measurements

System quality105,106

1992

Measure of the system
characteristics105,107

Ease of use, functionality,
reliability, flexibility, data
quality, portability,
verifiability, and
integration106–108

Information
quality105,106

1992

Measure of the
characteristics of the
information output provided
by the system105,107

Accuracy, timeliness,
completeness, relevance,
understandability, and
consistency106,107

Use105,106

1992

Measure of the use of the
information by decision
makers and intended users
in a voluntary context105,107

Frequency of use, selfreported use, actual use,
time of use, appropriateness
of use, number of accesses,
and usage pattern106–108

User
satisfaction105,106

1992

Measure of the satisfaction
experienced by decision
makers and intended users
in a non-voluntary
context105,107

Satisfaction ratings for
specific systems and scales
used to assess attitudes and
satisfaction105,107

Individual
impact105,106

1992

Measure of the effect of the
information on the behavior
of the recipient105

Job performance, decisionmaking performance, and
quality of work
environment106,108

Organizational
impact105,106

1992

Measure of the effect of the
information on the
performance of an
organization105

Costs and benefits,
contribution to company
profits, and return on
investment105,108
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Dimension

Model
Year

Description

Example Measurements

Service quality106

2003

Currency, reliability,
Measure of the service
provided by IS organizations responsiveness, assurance,
and empathy106,108
to end users106

Net benefits106
(replaces individual
and organization
impact)

2003

Measure of all impacts (e.g.,
individual, workgroup,
organizational, and industry)
and benefits of a
system106,107

Improved decision making,
improved productivity,
increased sales, cost
reductions, creation of jobs,
and economic
development107

Since its publication, this model has been widely accepted as a framework for IS success
measurements.107,108 Further research has focused on identifying the independent variables that
may “cause” this success. Research by Petter, DeLone, and McLean published in 2013 identifies
several variables that serve as strong determinants of overall IS success: enjoyment, trust, user
expectations, extrinsic motivation, and IT infrastructure.107 Several other variables were
identified as strong determinants for specific IS success dimensions. The following table
summarizes these findings.107
Table 6.

Determinants of IS Success Dimensions

Determinant

Overall IS
Success

System
Quality

Use

User
Satisfaction

Task compatibility

Strong

Attitudes toward technology

Strong

Enjoyment

Strong

Self-efficacy

Strong

Trust

Strong

User expectations

Strong

Technology experience

Individual
Impact

Strong
Strong

Management support

Strong
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Determinant
Extrinsic motivation

Overall IS
Success

System
Quality

Strong

User
Satisfaction

Individual
Impact

Strong

Organizational competence
IT infrastructure

Use

Strong
Strong

Strong

Adapted from Petter et al., 2013.

These determinants are the interrelated, independent variables for the dependent variable of IS
success. The following figure summarizes these relationships.
Figure 2.

Determinants and Dimensions of IS Success

Adapted from Petter et al., 2013, and DeLone and McLean, 2003.

The D&M IS Success Model has been applied to numerous IT systems, including the
implementation and use of data warehouses.109 Applying this model to data warehouse projects
is particularly important, as studies have reported project failure rates from 41-90%.110–112

Typically, studies applying the D&M IS Success Model survey or interview a sample group with
the goal of identifying factors that determine successful system implementation and use.109 Each
potential factor is measured using multiple items with responses recorded using a seven-point
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Likert-type scale with values ranging from strongly agree to strongly disagree.109,113 For
example, items measuring data quality include “Users have more accurate data now from the
data warehouse than they had from source systems” and “I can get data that is current enough to
meet my work needs.”109,113 Likert values are then converted to numeric values and analyzed
using a variety of statistical techniques, such as partial least squares, regression, and hypothesis
testing.7,109,110,113

Based on this analysis, several factors have emerged as critical to the successful implementation
and use of data warehouses. First, the quality of the data warehouse (system quality) and the
data (information quality) have been found to be key factors associated with net benefits of using
the system.108–110 Also influencing net benefits is the degree to which the features and functions
provided by the data warehouse align with business needs and user tasks.110,114 Management
support, training, and appropriate resources to implement and support the data warehouse have
been found to improve user satisfaction.7,108,109,114–118

3.2

Bloom’s Taxonomy of Educational Objectives

Because training was identified as an influencing factor within the TAM and D&M IS Success
Model, an understanding of educational objectives also provides a framework for this study.
Bloom’s Taxonomy of Educational Objectives (known as Bloom’s Taxonomy) is a framework
for classifying what students are meant to learn as a result of instruction.119 The goal of this
taxonomy is to help educators in two ways: to clarify their intended outcomes and to inform the
design of appropriate instruction and assessment methods.120 Originally envisioned as a method
for facilitating the exchange of test items among faculty at various higher education institutions,
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this taxonomy has become widely known, resulting in its translation into 22 languages and use in
all levels of education.119

The original taxonomy, published in 1956, provided six distinct levels of learning: knowledge,
comprehension, application, analysis, synthesis, and evaluation.119 These levels are organized in
a cumulative hierarchy, where the ordering is simple to complex and from concrete to abstract,
so that each simpler level must be mastered before the next more complex level.119 In 2001, a
revision of the original taxonomy was published, which provided changes to the naming of each
level to reflect more modern language.119–121 The following table describes each revised
level.119,121
Table 7.

Cognitive Levels within the Revised Bloom’s Taxonomy

Level

Description

Remember

Able to retrieve relevant information from long-term memory

Understand

Determine the meaning of instructional messages (oral, written, and
graphic)

Apply

Carry out or use a procedure in a given situation

Analyze

Break material into parts and detect how the parts relate to one another
and the overall concept

Evaluate

Make judgments based on criteria and standards

Create

Put elements together to create a novel, coherent whole or an original
product

This revision also identified four types of knowledge that could be assessed using the cognitive
levels.119,120 Three of these types were included in the original taxonomy (factual, conceptual,
and procedural) and a fourth (metacognitive) was added in the revision.119 The following table
describes each of these types and typical knowledge covered by each type.
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Table 8.

Knowledge Types within the Revised Bloom’s Taxonomy

Type

Description

Factual

Basic elements that a student

must know to be acquainted with 
and solve problems within a
specific discipline119,120

Conceptual

Interrelationships among the
basic elements that allow them
to function together119,120





Classifications and categories
Principles and generalizations
Theories, models, and structures119

Procedural







Subject-specific skills and
algorithms
Subject-specific techniques and
methods
Criteria for determining when to use
appropriate procedures119

Metacognitive




Typical Knowledge

How to do something
The methods of inquiry
The criteria for using skills,
algorithms, techniques, and
methods119,120




Knowledge of cognition, in

general

Awareness and knowledge of
one’s own cognition119,120


Terminology
Specific details and elements119

Strategic knowledge
Cognitive tasks, including
appropriate contextual and
conditional knowledge
Self-knowledge119

The combination of knowledge type and cognition level provides a two-dimensional
representation of learning objectives. For example, a learning objective that states, “identify the
four types of knowledge represented in Bloom’s taxonomy” would be factual knowledge at the
remember cognitive level. In contrast, a learning objective that states, “Design program-level
learning outcomes based on Bloom’s taxonomy” would be conceptual knowledge at the create
cognitive level.

Based on these dimensions, assessments are created to determine if the learning objectives have
been met. For the first example objective above, a simple multiple-choice test item may be
sufficient to confirm that this objective has been met. In the second example, a summative report
outlining the research performed to define and determine the outcomes, as well as the outcomes
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themselves, may be an appropriate assessment. These assessments should be linked to the
objectives as well as the content of the instruction provided.120

3.3

Application of Conceptual Frameworks in this Study

This study included a presentation intervention to raise awareness of data warehouses among
research teams, assessments of the awareness intervention and existing data warehouse training,
and definition and use of objective measures for data warehouse activities related to research
outcome achievement. This section summarizes the use of the conceptual frameworks in
designing each of these components.

The study approach mirrored the five innovation-decision stages identified in the DOI theory. In
the knowledge stage, Rogers recommends providing awareness-knowledge and how-to
knowledge to influence innovation and adoption. As a result, this study included an intervention
to provide awareness-knowledge and use of an existing training process to provide how-to
knowledge.

In the persuasion stage, individuals actively seek out information regarding the innovation and
mentally apply an innovation to their current or future states. As a result, this study included a
process for individuals to request access and training for a data warehouse. In addition, the
request involved in this process required the individual to identify potential applications of the
data warehouse in his/her research project.
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In the decision stage, individuals who try out an innovation are more likely to adopt that
innovation. As a result, part of the training provided within this study included hands-on
experience using a data warehouse.

In the implementation stage, individuals need support to put an innovation to use. As a result,
this study included distribution of support information (e.g., how to obtain access to the data
warehouse and who to contact with questions) during the awareness intervention and training.

In the confirmation stage, individuals decide to continue or discontinue using the innovation.
Deciding to discontinue can be due to a replacement innovation or disenchantment with the
innovation. As a result, the awareness intervention and training included information about the
benefits of using a data warehouse instead of paper chart review or EHR chart review for
common research tasks to influence replacement of the existing methods. In addition, the
awareness intervention and training provided realistic expectations about how the data
warehouse can be used for research purposes. Appropriate expectations were critical to avoid
disenchantment with data warehouses.

Based on the TAM and D&M IS Success Model, the awareness intervention and training
included the following:


Realistic expectations for system and information quality.



Information about the usefulness of a data warehouse for common research tasks (task
compatibility).



Description of the benefits that can be achieved using a data warehouse (net benefits).



Information for obtaining data warehouse support.
48

Using Bloom’s Taxonomy, the learning objectives for the awareness intervention and training
were written. This study included assessment of these learning objectives based on the
knowledge type and cognitive level.

This study also included a follow-up assessment 30 days after completion of training to assess
factors identified as significant by the TAM and D&M IS Success Model, including ease of use
for data warehouse tools, availability of support, and benefits and barriers to using a data
warehouse.

Finally, the TAM identifies the need to objectively measure the adoption and use of technology.
As a result, this study included measures of the number of requests for data warehouse access,
the number of requests for data warehouse training, and the number of individuals completing
the associated data warehouse activities to achieve their intended research outcomes.

The following table provides a summary of the conceptual frameworks and their application
within this study.
Table 9.

Summary of Conceptual Frameworks

Framework

Application to Study

Diffusion of Innovation
(DOI) theory






Provides the stages of innovation adoption, which were used as
the basis for the study approach.
Identifies the activities that indicate movement between the
stages of technology adoption, which were used assess the
progression of individuals from one stage to the next within the
study.
Describes reasons for discontinuing the use of an innovation,
which were used to inform potential barriers included in the
post-training assessment within this study.
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Framework

Application to Study

Technology Acceptance
Model (TAM) and
DeLone & McLean IS
Success Model





Bloom’s Taxonomy of
Educational Objectives




Describes key content influencing technology adoption
highlighted within the awareness presentation intervention and
the existing training.
Identifies key aspects influencing technology
adoption/acceptance, which provided the focus for the
assessments within this study.
Identifies that assessment of factors influencing technology
adoption should be combined with objective measurement of
system use, which provided the reason for including the
objective measurement component of this study.
Describes a framework for creation of learning objectives,
which was used to create objectives for the awareness
presentation intervention and existing training.
Provides levels of assessment based on objectives, which was
used to determine the appropriate assessment for each learning
objective identified for the awareness presentation intervention
and existing training.
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CHAPTER 4:

METHODS

Within this chapter, the research design and approach for this study are described. Details are
provided regarding the organization and target population involved; the research hypotheses,
procedures, and assessment tools for each of the study components; project information
describing the researcher’s role and the project’s timeline and budget; and the limitations of this
research study.

4.1

Research Design

This research study applied a mixed methods approach to evaluate a presentation intervention to
raise awareness of data warehouses, to assess existing data warehouse training, and to define and
use objective measures for data warehouse activities related to research outcome achievement.
While the majority of the data collected within this study were quantitative in nature, some
qualitative information was gathered to better understand the reasoning underlying the
quantitative responses.

4.2

Organizational Background

This research study was conducted with the Clinical and Translational Science Institute (CTSI)
of Southeast Wisconsin. Founded in 2010, the CTSI is a consortium of eight regional
organizations including the BloodCenter of Wisconsin (BCW), Children’s Hospital of Wisconsin
(CHW), Clement Zablocki VA Medical Center (VA), Froedtert Hospital, Marquette University
(MU), Medical College of Wisconsin (MCW), Milwaukee School of Engineering (MSOE), and
University of Wisconsin-Milwaukee (UWM).122 Awarded a $20 million CTSA in 2015, the
CTSI has a mission of advancing the health of the community through research and discovery.122
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Currently, the research portfolio includes more than 185 studies, including 47 collaborative
research studies.122 Within the CTSI, the BMI department provides consultative services,
solutions for data management (such as REDCap, Confluence, and OnCore), and access to
clinical data through the image de-identification service and the Clinical Research Data
Warehouse (CRDW).123 The CRDW and its use was the focus of this research study.

4.2.1

Overview of the CRDW

The CRDW is a data warehouse that contains data from a variety of sources including the
Froedtert & Medical College of Wisconsin EHR (Epic), CHW EHR (Epic), MCW physician
billing system (GE/IDX), Froedtert Hospital legacy systems (Affinity, Intellidose, and SIS), and
the MCW tissue bank.124 This data includes, but is not limited to, patient demographics,
diagnoses, clinical encounters, lab results, medications, procedures, specimen information,
enrollment in clinical trials, and information from clinical registries. Currently, the CRDW
includes more than 1.9 million patient records, 524 million patient encounters, and 2.9 billion
clinical facts.124

To access this data, the BMI department provides three self-service tools for querying the
CRDW and extracting data:


Informatics for Integrating Biology & the Bedside (i2b2) can be used to query the CRDW for
developing hypotheses, determining feasibility, obtaining cohort counts for grant
submissions, and defining cohorts for data analysis. All data queried through this tool is deidentified and is organized in a concept tree structure.
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TriNetX is an additional query tool that is sponsored by the pharmaceutical industry.124
Similar to i2b2, TriNetX can be used for developing hypotheses, determining feasibility,
obtaining cohort counts for grant submissions, and defining cohorts for data analysis. All
data queried through this tool is de-identified and is organized by demographics, diagnoses,
procedures, medications, lab results, and cohort analysis.



Honest Broker is a data extraction tool that can use manual input or queries from i2b2 or
TriNetX to extract data for an identified set of patients. The extractions may contain deidentified or identified data. While Honest Broker contains standard data tables that can be
used for extraction, individuals also have the option to have custom tables created based on
the needs of their studies.

4.2.2

Current CRDW Processes

Currently, the BMI department does not have a repeatable, standardized process for raising
awareness of the CRDW and related tools. Individuals learn about the CRDW in a myriad of
ways, such as through information on the CTSI website, conversations with other research team
members, and contact with the BMI department. Upon request, BMI representatives have
presented CRDW information at meetings for departments and/or research teams.

To obtain access to the CRDW tools, an individual joins the CTSI and confirms that he/she has
current Collaborative Institutional Training Initiative (CITI) training for Human Subjects
Research. Once these items are complete and a potential research project has been identified, the
individual completes a feasibility or data release agreement identifying the principal investigator,
a description of the research, and other relevant information such as the intended outcome of the
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project (e.g., grant submission and abstract). Currently, access to these tools requires that the
principal investigator be a member of the MCW faculty or have an adjunct faculty appointment
with MCW. In addition, individuals must have an MCW domain account.

Once the agreement is completed and access is granted, the individual may begin using
independently i2b2, TriNetX, and Honest Broker. In addition, the BMI Business Analyst
contacts the individual to offer one-on-one or small group training. The purpose of this
voluntary training is to review the data contained within the CRDW; discuss the proposed project
and potential to complete the project within the CRDW; and demonstrate use of the query and
extraction tools based on the project needs. Individuals are also provided contact information for
the BMI Business Analyst and encouraged to contact the analyst for assistance as needed. All
activity within the CRDW tools is tracked and documented using audit trails. These audit trails
have been in use since the inception of the CRDW tools.

On an annual basis, the CTSI BMI department provides information to NCATS regarding
achievement of program goals. Currently, this information includes number of individuals
granted access, number of training sessions completed, and general information about outcomes
achieved (such as the number of grant submissions completed). To provide this information, the
CTSI BMI department tracks all CRDW access and training requests in a system called RISE.
These requests have been tracked in RISE since 2016.

4.3

Study Overview

This research study was divided into four components. The following section provides a brief
introduction to these components, a listing of the research questions and hypotheses related to
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each component, a description of the target population for this study, a description of the roles
and responsibilities within the study team, and an overview of the data processing and analysis
performed.

4.3.1

Overview of Study Components

In the first component of this study, the awareness presentation intervention, a representative
from the BMI department delivered 20-minute presentations to members of the CTSI research
community. The purpose of these presentations was to raise awareness of the CRDW and its
potential benefits with the goal of influencing the participants to move to the next stage in the
DOI process (from knowledge to persuasion). To assess the knowledge obtained, participants
completed pre- and post-assessments that measured their knowledge of the CRDW, as well as
their self-reported likelihood to use the CRDW. To encourage participants to answer honestly
and without fear of judgment, no identifying information (e.g., name, role/position, or
department) was captured during the assessments. Increased accuracy of knowledge from pre- to
post-assessment, as well as an increase in the self-reported likelihood to use would indicate
progress in the DOI process to adopt the CRDW.

In the second component, the existing CRDW training process was assessed. Trainees
completed pre- and post-assessments during the training session to assess the knowledge
obtained and self-reported likelihood to use. In addition, trainees identified the potential
outcomes for which the CRDW could be used (e.g., poster presentation, grant submission, and
manuscript). To encourage trainees to answer honestly and without fear of judgment, no
identifying information (e.g., name, role/position, or department) was captured during the
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assessments. To assess progress from the knowledge stage of the DOI theory to the persuasion
stage, the study used an increase in the accuracy of knowledge as well as an increase in selfreported likelihood to use as measurements. Additionally, the study captured the number of
potential outcomes of CRDW use identified by trainees. An increase in the number of potential
outcomes identified was hypothesized to indicate progress in the DOI process to adopt the
CRDW.

In the third component, data from several BMI information systems was used to objectively
measure outcomes achieved from the first two components. First, based on the DOI theory, if
the awareness intervention was sufficient, the number of individuals requesting CRDW access
and training should increase as they move from obtaining awareness-knowledge to seeking out
more information about the CRDW as part of the persuasion stage. Within this study, data from
the request tracking system RISE were used to obtain objective measures of these counts. In
addition, if the training provided sufficient information, the majority of trainees should perform
the necessary CRDW activities within 30 days of training to achieve their intended research
outcomes. Currently, no objective measure exists for these activities; as a result, majority was
defined as “at least 50%.” Data from the feasibility agreement, data release agreement, and
CRDW tool audit trails were used to track trainee activity within the CRDW to objectively
measure trainee completion of the activities related to their intended research outcomes.

During the fourth and final component, trainees participated in a 30-day post-training
assessment. The purpose of this assessment was to explore what factors may have influenced
their decisions to adopt or reject use of the CRDW, as well as their completion of CRDW
activities related to their intended research outcomes. Because these assessments were linked to
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specific trainees, the study researcher provided an informational letter to each trainee indicating
the confidentiality of the results so as to encourage honest responses to assessment items.

4.3.2

Research Questions and Hypotheses

These four components answer the following research questions by testing the following
hypotheses:
Q1:

Is delivering a 20-minute presentation regarding CRDW basic functions and processes a
sufficient intervention to raise awareness of the CRDW for clinical and translational
research purposes?
H1:

Awareness presentations will increase the average number of correct answers
from the pre-assessment to the post-assessment.

H2:

Awareness presentations will increase the average self-reported level of
likelihood to use from the pre-assessment to the post-assessment.

H3:

The growth rate of CRDW access requests for individuals and projects will
increase during the awareness presentation intervention period in comparison to
the growth rate from 2016-2017 for the same time period.

H4:

The growth rate of CRDW training requests for research project teams will
increase during the awareness presentation intervention period in comparison to
the growth rate from 2016-2017 for the same time period.

Q2:

Does existing CRDW training provide sufficient information for trainees to perform the
CRDW activities related to their intended research outcomes?
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H5:

CRDW training will increase the average number of correct answers from the preassessment to the post-assessment.

H6:

CRDW training will increase the average number of identified potential outcomes
from the pre-assessment to the post-assessment.

H7:

CRDW training will increase the average self-reported level of likelihood to use
from the pre-assessment to the post-assessment.

H8:

Within 30 days of receiving CRDW training, at least 50% of individuals will
complete the CRDW activities required to achieve their intended research
outcomes.

Q3:

What potential factors influence trainees’ use of the CRDW for clinical and translational
research purposes?

4.3.3

Target Population

The target population for this study was members of the CTSI research community. For the
purposes of this study, “research community” was defined as anyone who conducts research
and/or participates as a research team member. This definition included, but was not limited to,
principal investigators, research coordinators, fellows, medical residents, research administrators,
and graduate students. The “CTSI” qualifier referred to anyone who was employed by one of the
eight organizations participating in the CTSI. For example, a research fellow employed by BCW
would be within the target population, while a research fellow employed by the Aurora Health
Care system would be excluded from the target population. In addition, all participants must
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read, speak, write, and comprehend the English language, as that is the language used within all
the CRDW tools and data.

4.3.4

Study Roles and Responsibilities

The principal investigator for this study was Katie McCarthy (identified as “study researcher”
throughout the remainder of this document). The study researcher was responsible for:


Developing the study design and protocol.



Developing the recruitment protocols.



Creating the assessment tools for the CRDW awareness presentation intervention, CRDW
training, and 30-day post-training follow-up.



Writing the protocol submission and obtaining approval from the Institutional Review Board
(IRB).



Performing data collection and analysis.



Entering and maintaining the study documentation and results.



Leading and managing all aspects of the study.

The study team also included two representatives from the BMI department, who served as
subject matter experts and participated in the execution of the study protocol. Kristen Osinski is
the BMI Business Analyst and served as the primary BMI support for the study researcher. With
direction from the study researcher, the BMI Business Analyst was responsible for developing
and delivering the CRDW awareness presentations and CRDW training sessions. She also
executed the recruitment protocols for the CRDW awareness presentations and 30-day
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post-training follow-up assessments and assisted with data collection. Finally, she participated in
review of all the assessments created by the study researcher.

Bradley (Brad) Taylor is the Chief Research Informatics Officer within the BMI department. He
served as the MCW and CTSI sponsor for this study. In this role, he approved the participation
of the BMI Business Analyst and ensured the study researcher had access to the BMI tools
necessary to complete the study. In addition, he assisted with recruitment for the CRDW
awareness presentations and delivered some of the CRDW awareness presentations.

4.3.5

Data Processing and Analysis

The study researcher performed data preparation, cleaning, and analysis using Microsoft Excel
2016, R version 3.5.1, and RStudio version 1.1.463. For all statistical tests, a level of
significance of 0.05 was used.

4.4

Study Component #1: Awareness Intervention

During this component, a member of the BMI department (the BMI Business Analyst or Chief
Research Informatics Officer) delivered a 20-minute presentation to a group of individuals from
the target population. During the presentation, participants completed pre- and post-assessments
to determine the knowledge obtained from the presentation content.

Should this presentation intervention prove sufficient for raising awareness of the CRDW, the
BMI department plans on implementing this intervention as a standard process. Based on this
plan, the minimum sample size for this component mirrored the 3-4 presentations per month that
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could be sustained by the BMI department as a standard process. Because the study period was
three months, the goal was completion of 9-12 presentations during the study period.

During refinement of the procedure and assessment tools for this component, an average of
seven individuals participated in each presentation, and 82% of these individuals participated in
the assessments. Using this information as a basis for determining minimum sample size, if
group sizes are 6-8 individuals and 75% participate in the assessment, the potential number of
completed assessments is 40-72 assessments. As a result, the minimum sample size for this
component is 40 completed pre-assessments and associated post-assessments.

Based on the recruitment protocol developed by the study researcher, a BMI department
representative (Business Analyst or Chief Research Informatics Officer) contacted leaders
identified as primary contacts for each CTSI partner organization to determine interest in
scheduling awareness presentations for groups within their organizations. When interest was
expressed by a leader, the BMI representative worked with that leader to schedule an appropriate
date, time, and location and obtained an estimate of the number of potential attendees. As part of
the recruitment protocol, the BMI representative also obtained verbal permission to conduct preand post-assessments during the scheduled session. If permission was obtained, the BMI
representative contacted the study researcher regarding the date and time of the session, location
of the session, and number of potential attendees. The study researcher used this information to
prepare the appropriate number of pre- and post-assessment copies for the session.
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4.4.1

Research Procedure

At the start of the scheduled session, the study researcher explained the purpose of this study and
pre- and post-assessments, as well as the voluntary nature of the study and the anonymity of the
results. To individuals who consented to participate, the study researcher then provided the
pre-assessment and an envelope to in which to store the completed pre-assessment. Once the
pre-assessments were complete, the BMI representative delivered the presentation and answered
any questions that were posed. At the end of the session, the study researcher provided each
individual who completed the pre-assessment with a copy of the post-assessment and instructed
the individual to store this post-assessment in the same envelope as the pre-assessment. Once the
assessments were completed, the study researcher collected all the envelopes. Finally, the
number of individuals attending the session and the number of pre- and post-assessment pairs
completed were documented.

Only presentations that covered the standard CRDW awareness presentation and conformed to
this protocol were included within this study component. For example, if a department requested
a CRDW presentation that only described one of the CRDW tools, then this presentation was not
the standard CRDW awareness presentation and was not counted as a presentation for the
purpose of this study component.

4.4.2 Content Development
Based on factors identified by the TAM and D&M IS Success Model as important for
technology adoption, the study researcher identified learning objectives for the CRDW
awareness presentation intervention. Specifically, perceived usefulness and task compatibility

62

were identified as strong determinants; therefore, the presentation objectives focused on key
elements related to research work that are supported by the CRDW. These objectives are listed
below.

At the completion of this presentation, attendees should be able to:


Identify the standard data elements available within the CRDW.



Identify the situations where use of CRDW data requires Institutional Review Board (IRB)
approval.



Identify the BMI services that are provided free-of-charge related to the CRDW.

Based on these objectives and direction from the study researcher, the BMI Business Analyst
developed the content of the awareness presentation. In addition, similar presentations have
been delivered previously by the BMI department, so experience gained from these presentations
was used to inform the structure and flow of this new presentation.
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Below is an example of one of the content slides developed for the presentation.
Figure 3.

Example Slide from Awareness Presentation Intervention

4.4.3

Assessment Tool Development

Using Bloom’s taxonomy, the study researcher classified the presentation objectives as factual
and conceptual knowledge at the remember cognitive level. Using these dimensions as a guide,
the study researcher created an assessment tool with a question related to each objective. The
goal of these questions was to determine if the learning objectives for the presentation were
achieved. A final question was developed to determine the individual’s self-reported likelihood
to use the CRDW, with a follow-up question if “unlikely” or “very unlikely” was selected to
determine the reason for this selection. The goal of this question was to obtain an indication of
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the individual’s attitude toward the CRDW (a key component of DOI theory and the TAM
model) and to gain some qualitative information for anyone indicating a low likelihood of use.

4.4.4

Refinement of Procedure and Assessment Tool

To refine the awareness presentation content, assessment, and procedure, the study researcher
and BMI Business Analyst delivered two presentations to different departments within the MCW
research community. A total of 17 individuals participated in these presentations, with
14 individuals completing the assessments (82%). Three individuals did not participate as they
arrived after the pre-assessments were completed. While the research procedure outlined above
was followed, the data captured on the assessments was not retained (as the sole purpose of these
sessions was to refine the content, tools, and procedure).

During this process, the study researcher identified the following improvements:


The original presentation contained too much content to be covered in 20 minutes. The study
researcher and BMI Business Analyst modified the content to meet the identified time
constraints. A copy of the final presentation is provided in Appendix B: Awareness
Presentation Content.



Because the pre- and post-assessments contain the exact same questions, the study researcher
copied pre-assessments on one color paper, while the post-assessments were copied on a
different color. This process proved helpful in distinguishing between the two assessments
when they were completed and placed within the same envelope. This process was
continued during the research study.
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The study researcher reworded the three questions related to the presentation learning
objectives to reduce ambiguity and better align with the presentation.



For the question relating to likelihood to use the CRDW, several individuals completed the
follow-up question even though they indicated a positive likelihood to use the CRDW. The
study researcher changed the formatting of the likelihood question and follow-up question to
more clearly indicate when the follow-up question should be completed.

In addition to these sessions, the study researcher had the assessment tool reviewed by an
individual with expertise in survey design. This review resulted in some minor wording changes,
but no substantial content changes. A copy of the revised assessment is provided in Appendix C:
Awareness Presentation Assessment Tool.

4.4.5

Data Processing and Analysis Procedure

The purpose of study component #1 was to test the following hypotheses:
H1: Awareness presentations will increase the average number of correct answers from the
pre-assessment to the post-assessment.
H2: Awareness presentations will increase the average self-reported level of likelihood to use
from the pre-assessment to the post-assessment.

To test hypothesis H1, the answers from the first three questions on the awareness presentation
assessments were analyzed. The first three questions are shown below.
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Figure 4.

First Three Questions from Awareness Presentation Assessment

Because question #1 had six possible answers, question #2 had one possible answer, and
question #3 had four possible answers, the maximum number of potential correct answers for
one assessment was eleven. Each assessment was reviewed to determine the number of correct
answers. For example, if an individual correctly identified five answers for question #1, zero
answers for question #2, and three answers for question #3, the individual’s correct answer score
was 8 (5 + 0 + 3).

The mean and standard deviation for the total number of correct answers were calculated for the
pre- and post-assessments. Bar charts and boxplots were used to visualize the results from these
questions as well as the overall number of correct answers from this section of the assessment.
Then, the study researcher tested the normality of the data using Q-Q plots and the results of the
Shapiro-Wilk normality tests. Based on the results of these tests, the study researcher performed
the appropriate parametric or non-parametric hypothesis testing method.
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To test hypothesis H2, the answers from the fourth question on the awareness presentation
assessments were analyzed. The fourth question is shown below.
Figure 5.

Fourth Question from Awareness Presentation Assessment

To process this data, each level of likelihood was assigned a numeric equivalent (“Very Likely”
was 4, “Likely” was 3, “Unsure” was 2, “Unlikely” was 1, and “Very Unlikely” was 0). The
mean and standard deviation for the level of likelihood were calculated for the pre- and postassessments. Bar charts and boxplots were used to visualize the results from this question.
Because this assessment data uses an ordinal scale of measurement, hypothesis testing was
performed using a non-parametric method (Wilcoxon matched-pairs signed-ranks test).

4.5

Study Component #2: Assessment of CRDW Training

This study component assessed the existing CRDW training process to determine if sufficient
information was provided for trainees to complete the CRDW activities related to their intended
research outcomes. During this component, the BMI Business Analyst delivered one hour of
CRDW training to one or more members of a research team. Because research teams often
contain individuals with unique skills and work is delegated based on these skills, trainees were
not required to have attended an awareness presentation prior to training. For example, a
principal investigator may have attended an awareness presentation, identified the potential uses
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for the CRDW in his/her research, and then selected one or more research team members to
receive CRDW training who had not attended the awareness presentation.

Because individuals receiving CRDW training may not have participated in the awareness
presentations, the CRDW training provided the same foundational knowledge covered in the
awareness presentation, but added hands-on practice using the CRDW for a research project
identified by the individuals receiving the training. During the training, pre- and
post-assessments were completed to determine if sufficient information was provided.

Because one of the hypotheses to be tested within this study was whether or not the number of
requests for CRDW training increases, the awareness presentation was the only recruitment used
for this component. Due to the anonymity of the participants in the awareness presentations, this
study component did not link those attending awareness presentations to those attending training
sessions. Based on experience gained during the refinement of the procedure and assessment
tool for this intervention, the goal was to have 75% of trainees complete a pre-assessment and
associated post-assessment.

4.5.1

Research Procedure

This intervention began when one or more members of a research team entered a CRDW
feasibility or data release agreement. Upon receipt of this agreement, the BMI Business Analyst
followed the current CRDW training process and contacted the requestor to determine if the
requestor (and associated research team members) wanted to schedule CRDW training.
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If interest was expressed, the BMI Analyst completed the following tasks within the current
CRDW training process:


Worked with the requestor to schedule an appropriate date, time, and location and obtained
the names of the individuals that would be attending the training.



Used the list of names to ensure each trainee had access to the CRDW.



Used the information from the agreement to determine the feasibility of completing the
indicated research project with the CRDW and prepared for the training demonstration.

During the scheduled session, the BMI Analyst followed the study protocol and explained the
purpose of this research study and the pre- and post-assessments, as well as indicated that
participation in the study was voluntary and the results were anonymous. Trainees who
consented to participate were provided the pre-assessment and an envelope in which to store the
completed pre-assessment. Once the pre-assessments were complete, the BMI Business Analyst
provided the training, allowed the trainees to try hands-on activities within the CRDW, and
answered any questions that were posed. At the end of the session, each trainee who completed
the pre-assessment was provided a copy of the post-assessment and asked to store this
post-assessment in the same envelope as the pre-assessment. Once complete, all the envelopes
were collected by BMI Business Analyst and then provided to the study researcher.

Only training sessions that covered the standard CRDW training content and conformed to this
protocol were included within this study component. For example, if a researcher requested
refresher training focusing on a specific area of confusion, then this training session did not
cover the standard CRDW training content and was not counted as a training session for the
purpose of this study component.
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4.5.2

Content Development

The BMI Business Analyst developed the existing CRDW training and has used this training
approach and content for approximately two years. As a result, no new content was developed.
The study researcher reviewed the existing content to ensure it provided the same CRDW
foundational knowledge as the awareness presentation. Based on this review, no revisions were
identified. Because the hands-on activities are based on the trainee’s potential research project,
no standard content was available for this portion of the training.

4.5.3

Assessment Tool Development

Trainees participating in this component may or may not have attended a CRDW awareness
presentation. For example, a research team manager may have attended an awareness
presentation and encouraged his/her research staff (who did not attend the presentation) to obtain
CRDW training. For this reason, the CRDW training provided the same foundational knowledge
as the awareness presentation to ensure that all trainees obtained the same base knowledge.

Because the CRDW training covered the same foundational knowledge as the awareness
presentation, the same three learning objective questions from the presentation assessment were
included on the training assessment tool. The goal of these questions was to determine if the
learning objectives for the training were achieved.

Because DOI theory indicates that individuals in the persuasion stage of technology adoption
will mentally consider ways to apply the technology to their current and future needs, the study
researcher developed a new question to identify the trainee’s intended outcomes in using of the
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CRDW. Currently, the feasibility and data release agreement forms for the CRDW include a
question that asks the individual to indicate his/her intended outcomes in using the CRDW. The
options that the individual may select are protocol, poster presentation, grant submission,
abstract, manuscript, and other. As a result, these same intended outcome options were used for
the new assessment question developed by the study researcher. The goal of this question was to
identify a trainee’s intended use of the CRDW before and after training.

Finally, the same question from the awareness presentation assessment related to an individual’s
self-reported likelihood to use the CRDW was included. The goal of this question was to obtain
an indication of the individual’s attitude toward the CRDW (a key component of DOI theory and
the TAM model) and gain some qualitative information for anyone indicating a low likelihood of
use.

4.5.4

Refinement of Procedure and Assessment Tool

To refine the training assessment and procedure, the BMI Business Analyst delivered two
training sessions to different research project teams within the MCW research community and
provided the results to the study researcher. A total of four individuals participated in these
presentations, with four individuals completing the assessments (100%). While the research
procedure outlined above was followed, the data captured on the assessments was not retained
(as the sole purpose of these sessions was to refine the tool and procedure).
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During this process, the study researcher identified the following improvements:


Because the pre- and post-assessments contain the exact same questions, the study researcher
copied pre-assessments on one color paper, while the post-assessments were copied on a
different color. This process proved helpful in distinguishing between the two assessments
when they were completed and placed within the same envelope. This process was
continued during the research study.



The study researcher reworded the three questions related to the training learning objectives
to reduce ambiguity and better align with the training. The changes made were aligned with
the changes identified during the awareness presentation refinement process.



For the question relating to likelihood to use the CRDW, several individuals completed the
follow-up question even though they indicated a positive likelihood to use the CRDW. The
study researcher changed the formatting of the likelihood question and follow-up question to
more clearly indicate when the follow-up question should be completed. The changes made
were aligned with the changes identified during the awareness presentation refinement
process.

In addition to these sessions, the study researcher had the assessment tool reviewed by an
individual with expertise in survey design. This review resulted in some minor wording changes,
but no substantial content changes. A copy of the revised assessment is provided in Appendix D:
CRDW Training Assessment Tool.
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4.5.5

Data Processing and Analysis Procedure

The purpose of study component #2 was to test the following hypotheses:
H5: CRDW training will increase the average number of correct answers from the preassessment to the post-assessment.
H6: CRDW training will increase the average number of identified potential outcomes from the
pre-assessment to the post-assessment.
H7: CRDW training will increase the average self-reported level of likelihood to use from the
pre-assessment to the post-assessment.

To test hypothesis H5, the answers from the first three questions on the training assessments
were analyzed. The first three questions are shown below.
Figure 6.

First Three Questions from CRDW Training Assessment
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Because question #1 had six possible answers, question #2 had one possible answer, and
question #3 had four possible answers, the maximum number of potential correct answers for
one assessment was eleven. Each assessment was reviewed to determine the number of correct
answers. For example, if an individual correctly identified five answers for question #1, zero
answers for question #2, and three answers for question #3, the individual’s correct answer score
was 8 (5 + 0 + 3).

The mean and standard deviation for the total number of correct answers were calculated for the
pre- and post-assessments. Bar charts and boxplots were used to visualize the results from these
questions as well as the overall number of correct answers from this section of the assessment.
Then, the study researcher tested the normality of the data using Q-Q plots and the results of the
Shapiro-Wilk normality tests. Based on the results of these tests, the study researcher performed
the appropriate parametric or non-parametric hypothesis testing method.

To test hypothesis H6, the answers from the fourth question on the training assessments were
analyzed. The fourth question is shown below.
Figure 7.

Fourth Question from CRDW Training Assessment

A total of six potential outcomes could be selected by the trainee. The mean and standard
deviation for the number of potential outcomes were calculated for the pre- and
post-assessments. Bar charts and boxplots were used to visualize the results from this question.
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Then, the study researcher tested the normality of the data using Q-Q plots and the results of the
Shapiro-Wilk normality tests. Based on the results of these tests, the study researcher performed
the appropriate parametric or non-parametric hypothesis testing method.

To test hypothesis H7, the answers from the fifth question on the training assessments were
analyzed. The fifth question is shown below.
Figure 8.

Fifth Question from CRDW Training Assessment

To process this data, each level of likelihood was assigned a numeric equivalent (“Very Likely”
was 4, “Likely” was 3, “Unsure” was 2, “Unlikely” was 1, and “Very Unlikely” was 0). The
mean and standard deviation for the level of likelihood were calculated for the pre- and
post-assessments. Bar charts and boxplots were used to visualize the results from this question.
Because this assessment data uses an ordinal scale of measurement, hypothesis testing was
performed using a non-parametric method (Wilcoxon matched-pairs signed-ranks test).

4.6

Study Component #3: Objective Measurement of Outcomes

The third study component involved obtaining data from several BMI information systems to
objectively measure outcomes achieved from the first two components. As this component
involves review of existing data, no recruitment procedures or goals were established for this
component.
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4.6.1

Research Procedure

The third component involved the study researcher obtaining data from several BMI information
systems to objectively measure outcomes achieved from the first two components. Specifically,
the following measures were obtained:


The number of CRDW access requests by individual and research project.



The number of CRDW training requests by research project team.



The number of trainees performing the CRDW activities related to their intended research
outcomes.

Currently, all requests for access and training for the CRDW are tracked within a system known
as RISE. These data have been tracked since 2016. To determine if the awareness intervention
was sufficient, the study researcher obtained RISE data for the number of requests for CRDW
access and training during the study time period. The study researcher used this data to
determine if the intervention had increased the number of requests in comparison to prior years.

To obtain the measurement of trainees performing the CRDW activities related to their intended
research outcomes, the first step was reviewing the list of trainees who completed training during
the study period. The study researcher linked the trainees to their intended outcomes (e.g.,
protocol, poster presentation, and grant submission) identified in the completed feasibility or data
release agreements. In addition, the study researcher requested CRDW audit trail data for each
of the trainees. The study researcher reviewed the audit trail data to determine if trainees
completed the appropriate actions within the CRDW to achieve their intended research
outcomes. For example, if the intended outcome was a grant submission, minimally, the
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researcher would likely use the CRDW for a potential cohort of patients that could be included in
the study. For this use case, completion of a query within the CRDW was required to achieve
the intended research outcome. Individuals who completed the necessary CRDW actions within
30 days of receiving training were identified as successfully completing the CRDW activities.
This timeline aligned with the 30-day post-training assessment; as a result, no CRDW activities
more than 30 days post-training were included as part of this study.

4.6.2

Refinement of Procedure

To determine if the objective measures for CRDW access and training requests were feasible, the
study researcher obtained a sample of data from the RISE system for 2016, 2017, and 2018.
Review of this sample confirmed that the necessary data for the applicable timeframes were
available in RISE and could be used to obtain the number of requests and growth rates for
analysis purposes. Because the existing request documentation provided the necessary
information for this study and to maintain consistency with historical data, no changes were
made to this tracking for this study.

To determine if the objective measure for CRDW activities was feasible, the study researcher
obtained a sample of data for feasibility agreements, data release agreements, and audit trails
from 2016, 2017, and 2018. Review of this sample confirmed that the necessary data for the
applicable timeframes were available and could be used to obtain the number of trainees that
completed the CRDW activities related to their intended research outcomes. Because the
existing request documentation provided the necessary information for this study and to maintain
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consistency with historical data, no changes were made to the CRDW feasibility agreements,
data release agreements, and audit trails for this study.

4.6.3

Data Processing and Analysis Procedure – Access Requests

The purpose of measuring CRDW access requests was to test the following hypothesis:
H3: The growth rate of CRDW access requests for individuals and projects will increase during
the awareness presentation intervention period in comparison to the growth rate from
2016-2017 for the same time period.

To test hypothesis H3, the CRDW access requests for the three-month study period (July 30
through October 30) in 2016, 2017, and 2018 were exported from the RISE system into a
Microsoft Excel file. Within this data file, the key fields included the date of the request, the
name and email of the principal investigator involved in the request, the project ID and name
associated to the request, the name of the individual for whom access should be granted, and the
type of tool for which access was granted. Individuals could request access to one or both types
of CRDW tools, and each type of tool was documented as a separate request. As a result, an
individual could have one or two records within the access dataset. For example, if an individual
requested access to the cohort tools (i2b2 and TriNetX), one record would exist for that
individual’s request. If the individual also requested access to Honest Broker, a second record
would exist for that individual.

To process this data, the study researcher first reviewed the file to identify any blanks, duplicated
requests, or obvious errors (such as records that were outside of the study period). If any issues
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were found, they were documented and resolved by the researcher. Next, the researcher
identified the number of unique individuals requesting access. If an individual had two requests
(one for the cohort tools and one for Honest Broker), these records were combined to avoid
double-counting the individuals. The researcher also identified the number of unique projects
associated to the access requests. If a project ID was associated to more than one request
(indicating multiple individuals requested access as part of that project), these requests were
combined to avoid over counting an individual project.

Once the study researcher identified unique records, the number of access requests by individual
and by project were counted for each year (2016, 2017, and 2018). The growth rates for
2016-2017 and 2017-2018 were calculated using the formula:
𝐺𝑟𝑜𝑤𝑡ℎ 𝑅𝑎𝑡𝑒 %

𝑥 100

The study researcher compared the calculated growth rates for 2016-2017 and 2017-2018 to
determine if the hypothesized growth occurred.

4.6.4

Data Processing and Analysis Procedure – Training Requests

The purpose of measuring CRDW training requests was to test the following hypothesis:
H4: The growth rate of CRDW training requests for research project teams will increase during
the awareness presentation intervention period in comparison to the growth rate from
2016-2017 for the same time period.

To test hypothesis H4, CRDW training requests for the three-month study period (July 30
through October 30) in 2016, 2017, and 2018 were exported from the RISE system into a
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Microsoft Excel file. Within this data file, the key fields included the date of the request, the
name and email of the principal investigator involved in the request, and the project ID and name
associated to the request. Each request within this dataset could involve one or more individuals
from a project team. In addition, a project team may request multiple training sessions. As a
result, the dataset could include multiple records for the same project.

To process this data, the study researcher first reviewed the file to identify any blanks or obvious
errors (such as records that were outside of the study period). If any issues were found, they
were documented and resolved by the researcher. Next, the researcher identified the number of
unique projects that had requested training. If a project ID was associated to more than one
request, these requests were combined to avoid over counting an individual project.

Once the study researcher identified unique records, the number of training requests by project
were counted for each year (2016, 2017, and 2018). The growth rates for 2016-2017 and 20172018 were calculated using the formula:
𝐺𝑟𝑜𝑤𝑡ℎ 𝑅𝑎𝑡𝑒 %

𝑥 100

The study researcher compared the calculated growth rates for 2016-2017 and 2017-2018 to
determine if the hypothesized growth occurred.
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4.6.5

Data Processing and Analysis Procedure – Outcomes

The purpose of measuring CRDW trainee completion of CRDW activities related to their
intended research outcomes was to test the following hypothesis:
H8: Within 30 days of receiving CRDW training, at least 50% of individuals will complete the
CRDW activities required to achieve their intended research outcomes.

To test hypothesis H8, a mapping table was created linking the intended research outcomes
identified on research teams’ Data Release Agreements with the appropriate actions within the
CRDW. Based on the expertise of the BMI Business Analyst, the following mapping table was
created.
Table 10.

Mapping Table for Intended Research Outcomes and CRDW Actions

Intended Outcome
Protocol

CRDW Actions
Query (in i2b2 and/or TriNetX)

Poster Presentation

Query (in i2b2 and/or TriNetX) and Extract (from Honest Broker)

Grant Submission

Query (in i2b2 and/or TriNetX)

Abstract

Query (in i2b2 and/or TriNetX) and Extract (from Honest Broker)

Manuscript

Query (in i2b2 and/or TriNetX) and Extract (from Honest Broker)

“Other” was also an option as an intended outcome. The BMI Business Analyst reviewed any
agreements in which this option was selected and determined the appropriate CRDW actions
based on other information provided within the agreement.

With the mapping complete, the next step was to obtain audit trail data from i2b2, TriNetX, and
Honest Broker for each of the trainees who participated in study component #2 (assessment of
CRDW training). For each trainee, a listing of his/her activities within 30 days of his/her
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training was aggregated from the separate CRDW tool audit trails, and then the listing was
compared to the appropriate CRDW actions based on intended research outcome. Trainees that
completed the mapped CRDW actions within 30 days of his/her training were identified as
successfully completing the CRDW activities.

4.7

Study Component #4: 30-day Post-training Assessment

The fourth and final component was designed to explore what factors may have influenced
individuals’ decisions to adopt or reject use of the CRDW, as well as their achievement of
outcomes. The study researcher contacted volunteers identified at the end of the CRDW training
sessions and asked them to complete a 30-day post-training assessment. This assessment
gathered quantitative and qualitative information about individuals’ perceptions of CRDW use,
which was used to explore potential reasons for CRDW adoption or rejection, as well as
completion or lack of completion of the CRDW activities related to their intended research
outcomes.

Recruitment for this study component occurred at the end of the CRDW training sessions.
Following the recruitment protocol, at the end of each CRDW training session, the BMI Business
Analyst asked each trainee if he/she was willing to participate in a 30-day post-training
assessment. If the trainee declined, the BMI Business Analyst documented the trainee’s name
and date of training and indicated that the trainee would not participate. This documentation
ensured the trainee was not inadvertently contacted for the last component of this study and that
a complete list of trainees was available at the end of the study. If the trainee consented, the
BMI Business Analyst documented the trainee’s name and date of training and indicated the
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trainee’s preferred follow-up method (in-person interview, phone interview, or email with an
electronic survey) and contact information. The goal was to have 10% of trainees complete the
30-day post-training assessment. This goal was based on previous response rates for similar
interview and survey data collection procedures.

4.7.1

Research Procedure

During the study, the study researcher accessed the list of trainees. For trainees who consented
to be contacted for a 30-day post-training assessment, the study researcher contacted each trainee
based on the identified preferred follow-up method.

For individuals who indicated a preference for an electronic survey, a link to the survey was sent
to the individual via email. The first email contact occurred within 30-38 days post-training. If
the survey was not completed within one week after the first contact, one additional follow-up
email was sent to remind the trainee to complete the survey.

For individuals who indicated a preference for an in-person or phone interview, the study
researcher contacted the trainee using his/her preferred contact method to schedule an
appropriate date, time, and location (if needed). The first contact occurred within 30-38 days
post-training. If needed based on lack of response, a second contact occurred one week after the
initial contact. For these interviews, the survey researcher asked the same questions that were
provided on the electronic survey. Trainees were provided the response scales for each question
to ensure consistency in responses.
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All responses completed within 30-45 days post-training were included in this study component.
In addition, responses to the interviews and electronic surveys were combined into a single
dataset for review and analysis.

4.7.2

Assessment Tool Development

The goal of the 30-day post-training assessment was to gather quantitative and qualitative
information about individuals’ perceptions of CRDW use, which could be used to explore
potential reasons for achievement or lack of achievement of outcomes. As a result, the study
researcher developed an assessment tool to gather information about key components the
technology adoption frameworks identify as strong determinants of use.

In the first section of the assessment tool, the individual was asked if he/she used the CRDW. If
the answer to this question was yes, further questions asked about the activities performed, the
perceptions of ease of use of the CRDW tools, and how the individual used the data (or plans to
use the data). The goal of this section was to document actual use, perceived ease of use, and
perceived usefulness of the CRDW.

The second section of the assessment tool determined if the individual requested support from
the BMI department regarding the CRDW. Because support was considered an important factor
in technology adoption, the goal of this question was to understand if individuals were using the
available support.

The third section of the assessment tools asked for individual perceptions of the potential
benefits or barriers to using the CRDW. Previous technology adoption framework research
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provided example survey items to measure factors influencing technology adoption. The study
researcher adapted these items to reference the CRDW and related tools. The goal of this section
was to gather information that could be used to explore potential reasons for completion or lack
of completion of the CRDW activities related to their intended research outcomes.

The fourth section addressed an individual’s self-reported likelihood to use the CRDW, which
was similar to the question that was included in the first two study component assessments. The
purpose of this question was to obtain an indication of the individual’s attitude toward the
CRDW (a key component of DOI theory and the TAM model) and gain some qualitative
information for anyone indicating a low likelihood of use.

The final section allowed the user to provide any additional comments about his/her experience
with the CRDW. The goal of this section was to capture information that individuals wanted to
provide but were not covered in the previous sections.

The study researcher documented this assessment tool in a Microsoft Word template that could
be used to record the results from in-person and phone interviews. Additionally, the tool was
built in an electronic survey tool (REDCap) for the emailed surveys.

4.7.3

Refinement of Procedure and Assessment Tool

The study researcher had the content of the assessment tool reviewed by an individual with
expertise in survey design. This review resulted in some minor wording changes, as well as a
format change to the third section. The written and electronic forms for the assessment were also
reviewed with the BMI Business Analyst for content and flow. This review resulted in some
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minor wording changes. No issues with survey flow were identified. A copy of the revised
assessment is provided in Appendix E: 30-day Post-training Assessment Tool.

Because the study researcher has conducted similar research procedures for other projects, no
additional refinement activities were performed for this research procedure.

4.7.4

Data Processing and Analysis Procedure

The purpose of study component #4 was to investigate potential factors that influence trainees’
use of the CRDW for clinical and translational research purposes, specifically within 30-45 days
of their original training.

The first section of the assessment gathered information about individual use of the CRDW. The
questions in this section are shown below.
Figure 9.

30-day Post-training Assessment – Section 1 Questions

If the answer to the previous question is Yes, the following additional questions appear:
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To process and analyze the data from the use of the CRDW question, the study researcher
obtained a count of each response and calculated the percentage of participating trainees
indicating they had used the CRDW since their training sessions.

If the trainee indicated that he/she had used the CRDW, then he/she would see the subsequent
three questions. For the first and third subsequent question, trainees could select more than one
option. As a result, the study researcher counted the number of responses for each option and
calculated the percentage of participating trainees indicating each option.

For the second subsequent question in this section, the number of options for answers were
collapsed to provide directional information due to the relatively small sample size in relation to
the number of options provided as answers. The options for rating of the ease of use of CRDW
tools included “Very easy to use,” “Easy to use,” “Difficult to use,” and “Very difficult to use.”
These ease of use ratings were collapsed into “Easy to use” (for “Very easy to use” and “Easy to
use”) and “Difficult to use” (for “Difficult to use” and “Very difficult to use”) to provide a
clearer summary of assessment answers. The study researcher counted the responses for each
rating and then determined any directional trends within the responses.
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The second section of the assessment gathered information about requests for CRDW support.
The questions in this section are shown below.
Figure 10.

30-day Post-training Assessment – Section 2 Questions

If the answer to the previous question is Yes, the following additional question appears:

To process and analyze the data from the CRDW support question, the study researcher obtained
a count of each response and calculated the percentage of participating trainees indicating they
had requested CRDW support since training. For the trainees indicating that they had requested
support, they would see the subsequent question. The study researcher reviewed these responses
to determine which individuals were contacted for CRDW support.

The third section of the assessment obtained individual perceptions of the potential benefits and
barriers to using the CRDW. The questions in this section are shown below.
Figure 11.

30-day Post-training Assessment – Section 3 Questions
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To analyze the data from this section of the assessment, the study researcher collapsed the
number of options for answers to provide directional information due to the relatively small
sample size in relation to the number of options provided as answers. The options included
“Strongly Agree,” “Somewhat Agree,” “Neither Agree nor Disagree,” “Somewhat Disagree,”
and “Strongly Disagree.” These options were collapsed into “Agree” (for “Strongly Agree” and
“Somewhat Agree”), “Neutral” (for “Neither Agree nor Disagree”), and “Disagree” (for
“Somewhat Disagree” and “Strongly Disagree”) to provide a clearer summary of assessment
answers. The study researcher counted the responses for each rating and then determined any
directional trends within the responses. The results were also visualized using bar charts
organized by positively and negatively worded statements.

The fourth section of the assessment obtained an individual’s self-reported likelihood to use the
CRDW. The question in this section is shown below.
Figure 12.

30-day Post-training Assessment – Section 4 Question

To analyze the data from this section of the assessment, the study researcher collapsed the
number of options for answers to provide directional information due to the relatively small
sample size in relation to the number of options provided as answers. The options included
“Very Likely,” “Likely,” “Unsure,” “Unlikely,” and “Very Unlikely.” These options were
collapsed into “Likely” (for “Very Likely” and “Likely”), “Unsure” (for “Unsure”), and
“Unlikely” (for “Unlikely” and “Very Unlikely”) to provide a clearer summary of assessment
answers. The study researcher counted the responses for each rating and then determined any
directional trends within the responses.
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The fifth and final section of the assessment allowed the individual to provide any additional
comments about his/her experience with the CRDW. The question in this section is shown
below.
Figure 13.

30-day Post-training Assessment – Section 5 Question

The study researcher reviewed any responses from this section and included them as part of the
analysis for the appropriate section. For example, if the individual included a comment that
he/she was unable to use the CRDW since training, the study researcher reviewed this comment
in the context of the other assessment answers. Due to the relatively small sample size for this
study component, no thematic analysis was performed based on the comments from this section
of the assessment.

4.8

Record Retention

For the pre- and post-assessments, as well as the 30-day post-training assessment, the study
researcher entered the results (answers to each assessment or follow-up question) into the
REDCap system hosted at Medical College of Wisconsin. REDCap (Research Electronic Data
Capture) is a secure, web-based application designed to support data capture for research studies,
providing 1) an intuitive interface for validated data entry; 2) audit trails for tracking data
manipulation and export procedures; 3) automated export procedures for seamless data
downloads to common statistical packages; and 4) procedures for importing data from external
sources.125,126 In addition, the study researcher entered the results into a Microsoft Excel
spreadsheet stored on an encrypted hard drive. This second copy served as confirmation of the

91

REDCap data entry and provided a backup should the REDCap data be lost or compromised.
The study researcher retained the original paper records (such as completed pre- and postassessments) in a secure location.

Additional electronic documentation generated during the study was stored in an MCW box.com
folder shared by the BMI Business Analyst and the study researcher. This additional
documentation could include, but was not limited to, data reports for the objective measurements
study component and backups of any Microsoft Excel spreadsheets used for data capture and/or
analysis. For backup purposes, the study researcher regularly copied these files to an encrypted
external hard drive owned by the researcher.

4.9

Researcher Role and Experience

For this project, the study researcher’s role was as principal investigator and evaluator for each
of the study components. Specifically, this included the creation of assessment tools, review of
data obtained from related CRDW data sources (such as audit trails and the RISE system), and
completion of the 30-day post-training assessments. These activities were feasible for the study
researcher to complete based on her background and professional experience.

The study researcher for this project has been a member of the CTSI since 2016 and has served
as an advisor for several CTSI Quality and Efficiency module projects, including two projects
for the BMI department. These experiences have allowed the study researcher to understand the
CTSI structure, learn about the BMI department, and become acquainted with key individuals
within the CTSI.
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In addition, the study researcher has more than twelve years of professional teaching experience
in higher education, including four years in a program director position. During this time, the
study researcher has developed more than 20 courses, redesigned the curricula for two degree
programs, and gained valuable insights by working with a professional instructional designer and
completing coursework in adult education. As a result, the study researcher has deep experience
developing course learning objectives and assessments and knowledge of adult education
principles.

Finally, the study researcher spent more than a decade in information-technology related roles
leading, managing, and supporting individuals and systems within three of the CTSI partner
organizations (BCW, Froedtert Hospital, and MCW). This experience includes more than seven
years implementing, supporting, and maintaining EHR-related software, interfaces, security, and
infrastructure. Experience gained leading enterprise EHR implementation projects has provided
the study researcher with critical, firsthand experience with technology adoption at both
individual and organization levels.

4.10 Institutional Review Board (IRB)
This study was approved by the Medical College of Wisconsin/Froedtert Hospital Institutional
Review Board (IRB) in accordance with 45 CFR 46.111 by expedited review, Categories 5 and
7, as a minimal risk study (see Appendix A: Institutional Review Board Approval Letter). As
part of existing IRB reliance master agreements, this approval was granted for the Medical
College of Wisconsin – Milwaukee campus, Milwaukee School of Engineering, and University
of Wisconsin-Milwaukee.
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4.11 Timeline and Budget
The study period timeline was 32 weeks, with most of the data collection and analysis for this
study occurring from August 2018 through November 2018. This timeline was chosen for
several reasons. First, many new researchers, residents, and students began working at CTSI
partner institutions during this timeframe. Having the interventions occur during this time period
provided the greatest opportunity to involve a diverse cohort of individuals. Second, this
timeframe allowed the study to be completed prior to the submission of the CTSA renewal
proposal, which is due in April 2019. Results from this study may be included within this
renewal packet as evidence of goal achievement. Finally, this timeline allowed sufficient time to
assess the outcomes of the awareness presentation and training, but was short enough to
minimize negative effects should these components result in ineffective or detrimental results.
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Below is the high-level timeline for this study.
Table 11.

High-level Timeline for the Study

From a budget perspective, the efforts of Bradley Taylor and Kristen Osinski from the BMI
department, as well as the use of REDCap software, were supported by the National Center for
Advancing Translational Sciences, National Institutes of Health, Award Number UL1TR001436.
The efforts of Dr. Luo (UWM advisor) and committee members (Dr. Cisler, Dr. Kate, Dr.
Patrick, and Dr. Payne) were provided at no cost to the project. The efforts of Katie McCarthy
were not monetarily compensated. The study participants were not compensated as part of this
study. As a result, no project budget allocation was needed for resources or participants.

This study involved procurement of office supplies such as pens, paper, envelopes, and printer
ink. The estimate for these costs was $500 and was provided by the study researcher. No other
costs were associated to this project.
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4.12 Study Methodology Limitations
Although this study has several strengths with the potential to make an important contribution to
literature regarding data warehouse adoption and use for clinical and translational research
purposes, there are potential methodology limitations that need to be noted.

First, although the CTSA hubs share common CRDW tools, such as i2b2, each CTSA hub has
variation in data warehouse implementation. For example, the Honest Broker tool used at the
CTSI is unique to that CTSI. As a result, further work would be needed to determine if these
study components could be generalized for use at other CTSA hubs, especially in relation to the
objective measures used.

Second, the 30-day post-training assessment population is based on volunteers identified at the
completion of CRDW training sessions. A potential exists that volunteer bias could exist within
this cohort. For example, only those individuals who feel confident in their use of the CRDW
may volunteer, which may cause results showing more activity than the overall trainee
population. Additionally, knowing that a 30-day post-training assessment exists may change the
behaviors of all trainees in relation to their use of the CRDW. For instance, trainees may rush to
complete their work within 30 days of training even if this would not be their normal behavior.

Finally, the 30-day post-training assessment focuses on individuals receiving CRDW training
and does not attempt to contact individuals who received access to the CRDW but did not
receive training. While focusing on individuals receiving training is reasonable based on the
desire to explore the link between training and completion of CRDW activities, it is possible that
choosing this population could result in bias (such as individuals who receive training are
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generally less comfortable with technology than those who choose not to receive training). As a
result of these limitations, care should be used when interpreting and attempting to generalize the
results of this study.
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CHAPTER 5:

RESULTS

Within this chapter, the results of each of the study components are presented, including the
acceptance or rejection of each of the study’s hypotheses.

5.1

Study Procedures and Timeline

After receiving IRB approval on July 26, 2018, data collection for this study occurred according
to the project timeline. Throughout the study, no deviations from the procedures described in the
previous chapter were encountered.

5.2

Study Component #1: Awareness Intervention

During the study period, seven presentations were held with a total of 54 participants attending.
Based on informal introductions occurring prior to the presentations, participants included
representatives from four of the eight CTSI partner organizations (CHW, MCW, MSOE, and
UWM) and held a variety of research-related roles (including investigators, academic faculty,
research coordinators, research administrators, laboratory management and staff, fellows,
medical students, and graduate students).

Of the 54 participants, a total of 50 participants attempted the pre- and post-assessments. Of
these 50 assessment pairs, one was found to be incomplete and was removed from the sample.
As a result, a total of 49 participants (91%) successfully completed the presentation pre- and
post-assessments, which exceeded the minimum sample size of 40 completed assessment pairs
originally proposed for this study.
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The purpose of study component #1 was to test the following hypotheses:
H1: Awareness presentations will increase the average number of correct answers from the
pre-assessment to the post-assessment.
H2: Awareness presentations will increase the average self-reported level of likelihood to use
from the pre-assessment to the post-assessment.

Below is a summary of the results for these hypotheses.

5.2.1

Hypothesis H1 Results – Correct Answers

To test hypothesis H1, the answers from the first three questions on the awareness presentation
assessments were analyzed. The maximum number of potential correct answers for one
assessment was eleven. Within the dataset, the total number of correct answers ranged from four
to eleven. In the pre-assessments, the mean (standard deviation) was 7.8 (1.6) total correct
answers. In the post-assessments, the mean (standard deviation) was 9.7 (1.2) total correct
answers.
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The figure below shows the frequency of the number of correct answers for the pre-assessment
and post-assessment.
Figure 14.

Correct Answers for Awareness Presentation Assessments

As shown in the figure above, the number of correct answers for the individual questions 1, 2,
and 3 increased from the pre-assessment (before the awareness presentation) to the
post-assessment (after the awareness presentation). The total number of correct answers for this
section also increased from the pre-assessment to the post-assessment. This supports hypothesis
H1.
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To visualize the change in the median number of total correct answers from pre-assessment to
post-assessment, a boxplot was created (and is shown below).
Figure 15.

Boxplot of Total Correct Answers for Awareness Presentation Assessments

As shown in the figure above, the median number of total correct answers from the
pre-assessments was 8 correct answers. The median number of total correct answers from the
post-assessments was 10 correct answers, which is an increase of two correct answers from the
pre-assessment. This supports hypothesis H1.

Next, the study researcher tested the normality of the data using Q-Q plots and the results of the
Shapiro-Wilk normality tests. Based on the results of these tests, normality could not be
assumed for this data; therefore, hypothesis testing was performed using a non-parametric
method (Wilcoxon matched-pairs signed-ranks test). The Wilcoxon matched-pairs signed-ranks
test indicated that the post-assessment scores were statistically significantly higher than
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pre-assessment scores (Wilcoxon T(37) = 241, p < 0.000, one-tailed test). As a result,
hypothesis H1 was accepted.

5.2.2

Hypothesis H2 Results – Likelihood to Use

To test hypothesis H2, the answers from the fourth question on the awareness presentation
assessments were analyzed. The possible options for this question were “Very likely” to “Very
unlikely.” Within the dataset, answers ranged from “Very likely” to “Unlikely.” No participants
selected “Very unlikely” in response to this question. In the pre-assessments, the mean (standard
deviation) was a 2.4 (0.9) level of likelihood. In the post-assessments, the mean (standard
deviation) was a 3.0 (1.0) level of likelihood.

The figure below shows the frequency of the levels of likelihood for the pre-assessment and
post-assessment.
Figure 16.

Levels of Likelihood for Awareness Presentation Assessments
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As shown in the figure above, the majority of participants indicated they were unsure if they
would use the CRDW in the pre-assessments (prior to the awareness presentations). In the
post-assessments (after the awareness presentations), the majority of participants indicated that
they were very likely or likely to use the CRDW, which indicates an increase in level of
likelihood from the pre-assessments to the post-assessments. This supports hypothesis H2.

To visualize the change in the median level of likelihood to use from pre-assessment to
post-assessment, a boxplot was created (and is shown below).
Figure 17.

Boxplot of Levels of Likelihood for Awareness Presentation Assessments

As shown in the figure above, the median level of likelihood was 2 (which is the numeric value
of the “Unsure” option) in the pre-assessments. In the post-assessments, the median level of
likelihood was 3 (which is the numeric equivalent of the “Likely” option). This increase
supports hypothesis H2.
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The Wilcoxon matched-pairs signed-ranks test indicated that the post-assessment likelihood
levels were statistically significantly higher than pre-assessment likelihood levels (Wilcoxon
T(9.5) = 83, p < 0.000, one-tailed test). As a result, hypothesis H2 was accepted.

5.3

Study Component #2: Assessment of CRDW Training

During the study period, eight training sessions were held with a total of 17 trainees attending.
Due to the anonymity of the awareness presentation participants, it is unknown if any of these
trainees attended the awareness presentations prior to receiving training. Of the 17 trainees, all
successfully completed the training pre- and post-assessments, which exceeds the 75%
participation rate originally proposed for this study.

The purpose of study component #2 was to test the following hypotheses:
H5: CRDW training will increase the average number of correct answers from the preassessment to the post-assessment.
H6: CRDW training will increase the average number of identified potential outcomes from the
pre-assessment to the post-assessment.
H7: CRDW training will increase the average self-reported level of likelihood to use from the
pre-assessment to the post-assessment.

Below is a summary of the results for these hypotheses.
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5.3.1

Hypothesis H5 Results – Correct Answers

To test hypothesis H5, the answers from the first three questions on the training assessments
were analyzed. The maximum number of potential correct answers for one assessment was
eleven. Within the dataset, the total number of correct answers ranged from three to eleven. In
the pre-assessments, the mean (standard deviation) was 7.6 (2.4) total correct answers. In the
post-assessments, the mean (standard deviation) was 9.3 (1.4) total correct answers.

The figure below shows the frequency of the number of correct answers for the pre-assessment
and post-assessment.
Figure 18.

Correct Answers for CRDW Training Assessments
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As shown in the figure above, the number of correct answers for the individual questions 1, 2,
and 3 increased from the pre-assessment (before the training session) to the post-assessment
(after the training session). The total number of correct answers for this section also increased
from the pre-assessment to the post-assessment. This supports hypothesis H5.

To visualize the change in the median number of total correct answers from pre-assessment to
post-assessment, a boxplot was created (and is shown below).
Figure 19.

Boxplot of Total Correct Answers for CRDW Training Assessments

As shown in the figure above, the median number of total correct answers from the
pre-assessments was 8 correct answers. The median number of total correct answers from the
post-assessments was 9 correct answers, which is an increase of one correct answer from the
pre-assessment. This supports hypothesis H5.
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Next, the study researcher tested the normality of the data using Q-Q plots and the results of the
Shapiro-Wilk normality tests. Based on the results of these tests, normality could not be
assumed for this data; therefore, hypothesis testing was performed using a non-parametric
method (Wilcoxon matched-pairs signed-ranks test). The Wilcoxon matched-pairs signed-ranks
test indicated that the post-assessment scores were statistically significantly higher than preassessment scores (Wilcoxon T(8.5) = 21, p = 0.005, one-tailed test). As a result, hypothesis H5
was accepted.

5.3.2

Hypothesis H6 Results – Potential Outcomes

To test hypothesis H6, the answers from the fourth question on the training assessments were
analyzed. A total of six potential outcomes could be selected by the trainee. Within the dataset,
the number of potential outcomes selected ranged from one outcome to five outcomes. In the
pre-assessments, the mean (standard deviation) was 2.4 (1.4) potential outcomes. In the
post-assessments, the mean (standard deviation) was 2.2 (1.3) potential outcomes.
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The figure below shows the frequency of the number of potential outcomes for the
pre-assessment and post-assessment.
Figure 20.

Number of Potential Outcomes for Training Assessments

Based on this figure, the majority of trainees indicated one potential outcome during the
pre-assessment (before the training session). In the post-assessment (after the training session),
the majority of trainees indicated one potential outcome. As a result, an increase in potential
outcomes identified did not occur. This does not support hypothesis H6.
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To visualize the change in the median number of potential outcomes from pre-assessment to
post-assessment, a boxplot was created (and is shown below).
Figure 21.

Boxplot of Number of Potential Outcomes for Training Assessments

As shown above, the boxplots for the pre-assessment and post-assessment show no difference in
the number of potential outcomes identified, which does not support hypothesis H6.

Next, the study researcher tested the normality of the data using Q-Q plots and the results of the
Shapiro-Wilk normality tests. Based on the results of these tests, normality could not be
assumed for this data; therefore, hypothesis testing was performed using a non-parametric
method (Wilcoxon matched-pairs signed-ranks test). The Wilcoxon matched-pairs signed-ranks
test indicated that the post-assessment potential outcomes were not statistically significantly
different than pre-assessment potential outcomes (Wilcoxon T(9) = 0, p = 0.824, two-tailed test).
As a result, hypothesis H6 was rejected.
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5.3.3

Hypothesis H7 Results – Likelihood to Use

To test hypothesis H7, the answers from the fifth question on the training assessments were
analyzed. The possible options for this question were “Very likely” to “Very unlikely.” Within
the dataset, answers ranged from “Very likely” to “Unsure.” No participants selected “Unlikely”
or “Very unlikely” in response to this question. In the pre-assessments, the mean (standard
deviation) was a 3.0 (0.7) level of likelihood. In the post-assessments, the mean (standard
deviation) was a 3.6 (0.6) level of likelihood.

The figure below shows the frequency of the levels of likelihood for the pre-assessment and
post-assessment.
Figure 22.

Levels of Likelihood for Training Assessments

As shown in the figure above, the majority of participants indicated they were likely to use the
CRDW in the pre-assessments (prior to the training sessions). In the post-assessments (after the
training sessions), the majority of participants indicated that they were very likely to use the
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CRDW, which indicates an increase in level of likelihood from the pre-assessments to the
post-assessments. This supports hypothesis H7.

To visualize the change in the median level of likelihood to use from pre-assessment to
post-assessment, a boxplot was created (and is shown below).
Figure 23.

Boxplot of Levels of Likelihood for Training Assessments

As shown in the figure above, the median level of likelihood was 3 (which is the numeric value
of the “Likely” option) in the pre-assessments. In the post-assessments, the median level of
likelihood was 4 (which is the numeric equivalent of the “Very Likely” option). This increase
supports hypothesis H7.

The Wilcoxon matched-pairs signed-ranks test indicated that the post-assessment likelihood
levels were statistically significantly higher than pre-assessment likelihood levels (Wilcoxon
T(3.5) = 8, p = 0.011, one-tailed test). As a result, hypothesis H7 was accepted.
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5.4

Study Component #3: Objective Measurement of Outcomes

Study component #3 involved the objective measurement of CRDW access requests, CRDW
training requests, and trainee completion of CRDW activities related to their intended research
outcomes. Below is a summary of the results for these measurements and related hypotheses.

5.4.1

Hypothesis H3 Results – Access Requests

The purpose of measuring CRDW access requests was to test the following hypothesis:
H3: The growth rate of CRDW access requests for individuals and projects will increase during
the awareness presentation intervention period in comparison to the growth rate from
2016-2017 for the same time period.

The following table summarizes the number of individuals requesting access to the CRDW
during the study period in 2016, 2017, and 2018, as well as the growth rate calculated
year-to-year.
Table 12.

CRDW Access Requests by Individual in 2016, 2017, and 2018

2016

2017

2018

Growth Rate
(2016-2017)

Growth Rate
(2017-2018)

26

61

39

135%

-36%

Based on this analysis, the growth rate of access requests by individual decreased by 36% during
the study period compared to the previous year.
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The following table summarizes the number of projects associated to CRDW access requests
during the study period in 2016, 2017, and 2018, as well as the growth rate calculated
year-to-year.
Table 13.

CRDW Access Requests by Project in 2016, 2017, and 2018

2016

2017

2018

Growth Rate
(2016-2017)

Growth Rate
(2017-2018)

15

31

18

107%

-42%

Based on this analysis, the growth rate of access requests by project decreased by 42% during the
study period compared to the previous year.

Because the growth rate for individual and project access requests decreased during the study
period instead of increasing as hypothesized, hypothesis H3 was rejected.

5.4.2

Hypothesis H4 Results – Training Requests

The purpose of measuring CRDW training requests was to test the following hypothesis:
H4: The growth rate of CRDW training requests for research project teams will increase during
the awareness presentation intervention period in comparison to the growth rate from
2016-2017 for the same time period.
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The following table summarizes the number of projects associated to CRDW training requests
during the study period in 2016, 2017, and 2018, as well as the growth rate calculated
year-to-year.
Table 14.

CRDW Training Requests by Project in 2016, 2017, and 2018

2016

2017

2018

Growth Rate
(2016-2017)

Growth Rate
(2017-2018)

8

20

9

150%

-55%

Note that nine training sessions were documented in RISE during the study period in 2018, but
only eight training sessions were part of the CRDW training assessment (study component #2)
that occurred during this same period. This discrepancy was the result of a refresher training
session that was held during the study period for an individual that previously received CRDW
training. Although this training session did not meet the criteria to be included in study
component #2 (assessment of CRDW training), this training session was included in the RISE
records as a training request (as RISE training requests include all types of CRDW training
provided).

Based on this analysis, the growth rate of training requests by project decreased by 55% during
the study period compared to the previous year. Because the growth rate for project team
training requests decreased during the study period instead of increasing as hypothesized,
hypothesis H4 was rejected.
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5.4.3

Hypothesis H8 Results – Outcomes

The purpose of measuring trainee completion of CRDW activities related to their intended
research outcomes was to test the following hypothesis:
H8: Within 30 days of receiving CRDW training, at least 50% of individuals will complete the
CRDW activities required to achieve their intended research outcomes.

Of the 17 trainees involved in study component #2 (assessment of CRDW training), four
individuals (24%) completed the appropriate CRDW actions mapped to their identified intended
research outcomes. Because less than 50% of individuals receiving training completed the
CRDW activities required to achieve their identified research intended outcomes, hypothesis H8
was rejected.

5.5

Study Component #4: 30-day Post-training Assessment

The purpose of study component #4 was to investigate potential factors that influence trainees’
use of the CRDW for clinical and translational research purposes, specifically within 30-45 days
of their original training. Of the 17 trainees that participated in study component #2 (assessment
of CRDW training), 16 trainees (94%) consented to be contacted for a 30-day post-training
assessment. Of the consenting trainees, a total of ten participants successfully completed the
assessment within 30-45 days of their original training, resulting in a 59% participation rate.
This participation rate exceeds the 10% rate originally proposed for this study component.

Additionally, of the trainees who completed the 30-day post-training assessment, two trainees
(20%) completed the CRDW activities related to their intended research outcomes and eight
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trainees (80%) did not complete the CRDW activities related to their intended research outcomes
in study component #3 (objective measurement of outcomes). This achievement ratio is similar
to the ratio for all the trainees who participated in this study.

Although the participation rate was higher than originally proposed, the sample size is relatively
small in relation to the number of options provided as answers. For example, the options for
rating of the ease of use of CRDW tools included “Very easy to use,” “Easy to use,” “Difficult to
use,” and “Very difficult to use.” As a result, the number of options were collapsed to provide
directional information as previously described.

5.5.1

Section #1: Use of the CRDW Tools

In the first section of the assessment, individuals were asked if they used the CRDW. If so,
further questions asked about the activities performed, the ease of use of the CRDW tools, and
how the data has been (or will be) used. Six of the ten trainees (60%) indicated that they had
used the CRDW tools since receiving training and, therefore answered three additional questions
related to CRDW use.

The first question asked trainees to identify the activities they completed using the CRDW tools.
Six trainees (100%) had obtained a count of patients within a particular cohort. One trainee also
analyzed the demographic distribution and extracted data tables for a patient set.

The second question asked trainees to rate the ease of use of each of the CRDW tools. Based on
the responses to this question, the majority of trainees found i2b2 and Honest Broker easy to use,
while trainees were evenly split on the ease of use of TriNetX.
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The third question asked trainees how they have used or plan to use the data obtained from the
CRDW. Trainees were allowed to select one or more of five possible plans. The most common
selection was using the data for cohort discovery (three trainees), closely followed by using the
data for prospective studies (two trainees) and using the data for retrospective studies (two
trainees).

5.5.2

Section #2: Requesting Support

In the second section of the assessment, trainees were asked if they contacted the BMI
department to receive CRDW support. Four trainees (40%) indicated that they had requested
support from the BMI department. Of these trainees, all contacted the BMI Business Analyst to
obtain this support. Two of the four trainees also provided information within the comments
section of the assessment, identifying the BMI Business Analyst as being an effective resource
and phenomenal in providing education and support.

5.5.3

Section #3: Benefits and Barriers to CRDW Use

In the third section of the assessment, trainees were asked about their perceptions of potential
benefits and barriers to using the CRDW. The figure below shows the level of agreement for
each of these statements. The left column of graphs shows the results for the three positively
phrased statements; the right column shows the results for the three negatively phrased
statements.
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Figure 24.

Responses to Benefits and Barriers Statements

5.5.4

Section #4: Likelihood to Use the CRDW

In the fourth section of the assessment, trainees were asked about their level of likelihood to use
the CRDW for future clinical research. Eight trainees (80%) reported being likely to use the
CRDW again.

One trainee (10%) reported being unsure of using the CRDW in the future. In the comments
section of the assessment, this trainee identified that he/she had not yet had an opportunity to
access the data within the CRDW, but felt the CRDW would be beneficial in the future. This
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trainee expressed a concern that receiving training and not using it immediately may present
some problems, but the trainee also identified that he/she knew how to reach out for support.

One trainee (10%) reported being unlikely to use the CRDW in the future. In this trainee’s
assessment responses, he/she identified lack of support, difficulty using the Honest Broker tool,
and lack of availability of needed data within the CRDW as potential barriers. The trainee also
somewhat disagreed with the statement that the CRDW was beneficial for his/her work. The
trainee did not request support from the BMI department. The trainee did not provide any
further comments within his/her assessment responses.
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CHAPTER 6:

DISCUSSION

The purpose of this study was to assess and measure the impact of raising awareness and
providing training on the completion of CRDW activities related to intended research outcomes.
This study also explored potential factors that influenced the completion of CRDW activities.
Specifically, three research questions were examined:
Q1: Is delivering a 20-minute presentation regarding CRDW basic functions and processes a
sufficient intervention to raise awareness of the CRDW for clinical and translational research
purposes?
Q2: Does existing CRDW training provide sufficient information for trainees to perform the
CRDW activities related to their intended research outcomes?
Q3: What potential factors influence trainees’ use of the CRDW for clinical and translational
research purposes?

Four study components were used to investigate these questions. The previous chapter presented
detailed results from each of these components. This chapter will provide an overall summary of
the findings, the interpretation of the findings by research question, the limitations of the study,
and the implications of the findings for future research.
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6.1

Summary of Study Findings

The following table presents the eight hypotheses tested in this study and indicates if the
hypotheses were supported based on the findings from each study component.
Table 15.

Assessment of Study Hypotheses

Hypothesis
Supported

Hypothesis
Research Question #1
H1: Awareness presentations will increase the average number of correct
answers from the pre-assessment to the post-assessment.

Yes

H2: Awareness presentations will increase the average self-reported level
of likelihood to use from the pre-assessment to the post-assessment.

Yes

H3: The growth rate of CRDW access requests for individuals and
projects will increase during the awareness presentation intervention
period in comparison to the growth rate from 2016-2017 for the same time
period.

No

H4: The growth rate of CRDW training requests for research project
teams will increase during the awareness presentation intervention period
in comparison to the growth rate from 2016-2017 for the same time
period.

No

Research Question #2
H5: CRDW training will increase the average number of correct answers
from the pre-assessment to the post-assessment.

Yes

H6: CRDW training will increase the average number of identified
potential outcomes from the pre-assessment to the post-assessment.

No

H7: CRDW training will increase the average self-reported level of
likelihood to use from the pre-assessment to the post-assessment.

Yes

H8: Within 30 days of receiving CRDW training, at least 50% of
individuals will complete the CRDW activities required to achieve their
intended research outcomes.

No
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6.2

Research Question #1: Raising Awareness of the CRDW

The approach of this study mirrored the five innovation-decision stages identified in the DOI
theory. As a result, research question #1 (Q1) was used to determine if a specific intervention
(presentation) to raise awareness was successful in increasing knowledge of the CRDW, as well
as moving individuals into the persuasion stage, where individuals actively seek out information
regarding the CRDW.

Based on the results for research hypotheses H1 and H2, the presentation did increase
participants’ knowledge of the CRDW, as well as their self-reported level of likelihood to use the
CRDW, both of which would indicate a successful awareness intervention. In reviewing the
results of hypotheses H3 and H4, the number of CRDW access and training requests did not
increase as anticipated, but instead decreased during the study period when compared to previous
years. As a result, while the knowledge stage was reached, the persuasion stage was not reached
during the study period.

One possible explanation is that the awareness intervention may have been successful (as
indicated by the increase in knowledge and likelihood to use), but the timeline for the study did
not provide adequate time for individuals to complete the steps necessary to request access
and/or training. For example, completion of the Data Release Agreement (the first step in
CRDW access) requires that the principal investigator for the intended project be MCW faculty.
Individuals from other CTSI partner sites who attended the awareness presentations may have
needed time to find an MCW collaborator and, therefore, may not have requested access during
the study period.
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Another possible explanation is that participants may have proactively attended the CRDW
presentations to understand the availability of CRDW tools for future research that may not
occur for months or years. While participants were asked about their likelihood to use the
CRDW before and after the presentation and the likelihood of use increased, they were not asked
about their potential timelines for using the tools. As a result, the BMI department may see an
influx of access and/or training requests after this study as grant submission deadlines approach.
Fortunately, because the schedule of presentations has been documented, requests could be
monitored to determine if there is a spike after the study period.

One further explanation is that the awareness presentation intervention provided sufficient
information for participants to identify that the CRDW tools and/or data would not meet the
needs of their current research projects. In this scenario, an individual would not have
immediately requested access or training for the CRDW, but may request access and/or training
for future research projects. This explanation is supported by the increase in the likelihood to
use level identified in the post-assessments, but the lack of immediate increase in access and
training requests for the CRDW.

Limited historical data and lack of a standardized awareness process may also have affected the
results for hypotheses H3 and H4. The requests for CRDW access and training have been
tracked since 2016. As a result, only two growth rates exist for comparison (2016 to 2017 and
2017 to 2018). Because a significant spike in requests was tracked in 2017, the 2016-2017
growth rates significantly increased. To have a higher 2017-2018 growth rate, an even more
significant spike in requests would need to occur in 2018. If the large number of requests in
2017 was an anomaly, comparing the growth rate from 2017-2018 to the growth rate from
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2016-2017 may be misleading. Without additional historical data, no conclusion can be drawn
about a “typical” year-to-year growth rate. Additionally, without a standardized process for
raising awareness, no documentation exists of activities that may have affected the number of
2017 requests. Fortunately, as requests continue to be tracked, a retrospective review could be
completed to review the number of requests year-to-year to determine typical growth rates. As a
result of this study, the BMI department also has documentation of when CRDW awareness
presentations and training sessions occurred, and they could use this information to review
changes in request rates after the study period.

A final possible explanation is that the awareness presentation content was insufficient to move
individuals from the knowledge stage to the persuasion stage. While the content of the
presentation was focused on factors found to be important in technology adoption, these factors
and the approach to delivering the content were not confirmed with the target population prior to
performing this study. For example, although the presentation focused on the data available
(which was identified as important for perceived usefulness and task compatibility), the actual
content may have focused too much on specific data elements available and not on stories of how
the available data had been used for research purposes (which may have been the focus desired
by the target population). As a result, the increase in knowledge and likelihood to use may have
been insufficient to cause immediate requests for access and training.
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6.3

Research Question #2: Achievement of Outcomes Post-training

For research question #2 (Q2), the goal was to determine if the CRDW training provided
sufficient information for trainees to complete the CRDW activities related to their intended
research outcomes. Based on the results for research hypotheses H5 and H7, the training does
increase knowledge of the CRDW and self-reported likelihood to use the CRDW. Interestingly,
training did not significantly change the number of potential outcomes identified by trainees
(research hypothesis H6). In addition, only 24% of the trainees completed the CRDW actions
related to their intended research outcomes within 30 days of completing training (research
hypothesis H8). As a result, while the persuasion stage was reached, the decision stage was not
reached during the study period.

For research hypothesis H6, trainees were asked to identify their intended outcomes from using
the CRDW. The intended outcome options included protocol, poster presentation, grant
submission, abstract, manuscript, and other. Trainees were allowed to select one or more (up to
a maximum of six) of these intended outcomes. Within this study, no significant change in the
number of intended outcomes existed between the pre-assessments and the post-assessments.
One explanation is that trainees discovered (during training) that the CRDW would not be useful
for their intended research projects. This explanation is contradicted, though, by the likelihood
to use indicated by the trainees, which increased from pre-assessment to post-assessment.

To investigate this contradiction further, the intended outcomes selected in the pre-assessment
and post-assessment by individual trainee were compared. In addition, for each individual
trainee, the likelihood to use value was compared between the pre- and post-assessment. Finally,
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a numeric change in level of likelihood to use was calculated. For example, if a trainee indicated
he/she was unsure about using the CRDW in the pre-assessment, and then indicated being very
likely to use the CRDW in the post-assessment, this was a two-level change in likelihood to use
(since the likelihood to use level increased by two). Below are the results of this investigation.
Table 16.

Comparison of Intended Outcomes and Likelihood to Use

Change in
Likelihood to Use

Number of
Trainees

Intended Outcomes
Increased

Stayed the Same

Decreased

1 trainee

2 trainees
1 trainee

Increased by two
levels

3

Increased by one
level

5

1 trainee

3 trainees

No change in
likelihood to use

8

2 trainees

6 trainees

Decreased by one
level

1

Totals

17

1 trainee
3 trainees

11 trainees

3 trainees

Within these results, an interesting pattern occurs. For trainees indicating a significant change in
the likelihood to use the CRDW (two levels), the majority of trainees indicated fewer intended
outcomes of CRDW use after training. For trainees indicating a small change (one level) or no
change in likelihood to use, the majority of trainees indicated the same number of intended
outcomes in the pre- and post-assessment. One explanation is that trainees with a significant
change in likelihood to use were able to focus on a specific task they wanted to complete with
the CRDW, so they reduced their number of intended outcomes as a result.

Further research is needed to determine if this pattern continues to emerge with a larger group of
trainees. Additionally, future research should include questions to obtain qualitative information
about the selection of intended outcomes, such as asking trainees about why they selected
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specific outcomes. The goal of this qualitative information would be to understand, more fully,
the link between outcomes and likelihood to use. Also, because the training pre- and postassessments were de-identified for this study, the study researcher was unable to correlate these
findings with a trainee’s completion of activities within the CRDW. For example, the study
researcher could not determine if trainees with a significant change in likelihood and a lower
number of intended outcomes completed the CRDW activities related to their intended research
outcomes at a greater rate than other trainees. Future research should identify the trainee in the
pre- and post-assessments so that these results can be correlated with the results of reviewing
audit trails of CRDW activity.

For research hypothesis H8, only 24% of the trainees completed the CRDW actions related to
their intended outcomes within 30 days of completing training instead of the hypothesized 50%
or greater. One of the most likely explanations for these results is the 30-day window for posttraining follow-up was insufficient based on the intended outcomes identified in the feasibility
and/or data release agreements by the particular trainees involved. Within these agreements,
trainees could select one intended outcome of requesting access to the CRDW tools. Of the 17
trainees who participated, ten trainees (59%) identified creation of a manuscript as the intended
outcome within their feasibility/data release agreements and seven (41%) identified “other”
intended outcomes. For those identifying other intended outcomes, most involved innovative
quality improvement projects or investigation of new care models, which are significant
undertakings. For all but one trainee, the outcomes identified were linked to completion of a
query (typically to identify an appropriate patient cohort) and then a data extraction (either to
obtain data about specific patients or obtain identified patient information used for completion of
chart review). While most trainees (82%) completed the query activities within 30 days, only
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four completed the data extraction within that timeline. Considering this timeline in the context
of the intended outcomes, this timing is logical; teams may initially query to determine if a
sufficient patient population exists to perform their studies, but then may need time to refine their
research hypotheses and protocols before performing the data extraction. These activities can be
time-consuming and may not fit within a 30-day window.

This explanation seems to be supported by the results from two of the components within this
study. First, within the 30-day post-training assessment, four of the ten respondents identified a
neutral or agreement response to the “I lacked the time to effectively use the CRDW” statement,
which may indicate that 30 days is insufficient time to begin working with CRDW tools. In
addition, one of the comments from this assessment identified that a trainee had not yet had the
time to use the CRDW for his/her work. Second, when reviewing one of the early trainee’s
achievement of intended outcomes using audit trail data, the trainee completed the needed query
within the 30 days post-training, but did not complete the extraction until three months later
(which happened to be within the timeline of the audit trails obtained, but outside of the 30-day
window for that particular trainee). Fortunately, because the training dates for all of the
participating trainees are known, CRDW activity could be reviewed at a later date to determine if
a longer study period would change the results for the completion of CRDW activities.

Further evidence for this explanation may be the lack of change in the number of potential
outcomes identified by participants before and after training as part of the pre- and postassessments. In creating the training assessment, a base assumption was that trainees would
already have been planning to use the CRDW in every way possible to support their research,
implying that trainees would query and extract all data from the CRDW. As a result, the training
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assessment measured only whether or not new research outcomes could be envisioned after
training.

A better approach may have been to gauge the trainee’s planned activities within the CRDW
before and after training. For example, a trainee may have identified using the CRDW for
creation of a study protocol and grant submission. Prior to starting training, this trainee may
have intended to use the CRDW only to obtain cohort information. However, during training,
the trainee discovered the potential to extract some of the needed data from the CRDW. While
the potential outcome of using the CRDW would not change (still being a study protocol and
grant submission), the intended activities to be performed in the CRDW may change.

If trainees’ planned activities within the CRDW changed as a result of training, further evidence
exists for the 30-day window being too short to assess outcome achievement. In the above
example, if the trainee discovered the potential to extract information from the CRDW, the
trainee may also have had to reconsider his/her data gathering plans, which could require more
than 30 days to complete.

6.4

Research Question #3: Factors Influencing CRDW Use

For research question #3 (Q3), the goal was to explore potential factors that influence trainees’
use of the CRDW for clinical and translational research purposes, specifically within 30-45 days
of their original training.

Based on the findings for the previous research questions, time may be the most significant
factor in CRDW use. From the initial time to find an MCW collaborator to the time needed to
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refine data gathering processes, trainees may “feel” that their existing processes require less time
than this “new” technology.

Ease of use may also be a factor (and may be correlated to the “time” factor). Within the 30-day
post-training follow-up assessment, the ease of use ratings by tool and the responses to the
statement “Overall, I found the CRDW easy to use” were somewhat mixed. Of the ten trainees
completing the assessment, most agreed that the CRDW was easy to use. Of the six trainees that
had used the tool since training, three identified TriNetX, two identified i2b2, and one identified
Honest Broker as difficult to use. However, caution was exercised in using the ease of use ratings
to determine which tool(s) may be challenging. In this section of the assessment, a “Did not use”
option was originally planned, but was mistakenly omitted from the final assessment provided to
all of the trainees. Although only one trainee identified this issue in his/her comments on the
assessment, it is unclear if the six trainees who responded to this question rated the ease of use
based on experience or simply selected a rating to be allowed to complete the remainder of the
assessment. As a result, further investigation is required to determine if ease of use is a
significant factor.

The type of CRDW support available may also be a factor. Currently, support is available by
contacting the BMI Business Analyst. Trainees that pursued this support provided positive
comments within the 30-day post-training assessment. Interestingly, two respondents who
reported a lack of support did not contact the BMI department. These respondents may have
preferred another form of support (such as the ability to search online information about the
CRDW or view tutorial videos). As a future step, follow-up could occur with these trainees to
determine if additional types of support would be a significant factor in use of the CRDW.
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Finally, the data available within the CRDW may be a factor. Of the ten trainees responding to
the 30-day post-training assessment, four either agreed with or provided a neutral response to the
statement “The data I needed was not available within the CRDW.” Should the CRDW lack data
needed for research, this may also explain why most trainees did not perform a data extraction
from the CRDW and, therefore, did not achieve their intended outcomes as defined in study
component #3 (objective measurement of outcomes).

From the 30-day post-training assessment responses, training is not seen as a barrier to CRDW
use, as all trainees felt that they received sufficient training.

6.5

Implications of the Findings

The purposes of this study were to identify interventions that increase research team awareness
of data warehouses, to assess outcomes of data warehouse training, and to define objective
measures for determining if research teams complete the data warehouse activities related to
their intended research outcomes. The following section discusses the implications of the study
findings on achieving these purposes.

The findings of this study indicate that an awareness presentation intervention can increase
research team knowledge of the CRDW, as well as their self-reported likelihood to use. This
intervention alone does not appear to result in increased CRDW use within a 90-day period.
Several implications can be derived from this finding. First, this finding serves as an initial
baseline that can be used for future research timelines. Second, awareness interventions need to
be tailored to the target population. Failure to check the awareness presentation content and
delivery with representatives from the target population may have reduced the effectiveness of
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the intervention. Finally, interventions should include an assessment item to understand the
timeline that individuals have for pursing adoption of new technology. For example, individuals
who participated in this study’s presentations may have done so planning for research that they
do not intend to pursue for several months. Understanding these timelines is critical to refining
two of the initial objective measurements within this study: the number of access CRDW
requests and the number of CRDW training requests.

This study also found that a majority of trainees did not complete the CRDW activities related to
their intended research outcomes within 30 days of receiving CRDW training. Two key
implications can be identified from this finding. First, the definition of “outcome achievement”
needs to be refined with assistance from the target population. Within this study, the definition
of “outcome achievement” was derived based on the experience of the key training and support
individual for the CRDW. While this definition is a sufficient baseline, the next step should be
working with individuals from the target population to obtain their feedback on this definition
and what they consider “outcome achievement” related to data warehouse use. A second
implication from this finding is that more research is needed to understand the timeline for
trainees to complete activities post-training, as the 30-day window appears to be too short based
on initial findings. Additionally, the appropriate window may vary depending on the intended
research outcomes identified by the trainee.

Similar to other research using the conceptual frameworks that served as the basis of this study,
time, ease of use, type of support, and availability of data appear to be potential factors
influencing CRDW use and achievement of outcomes. Future work is needed to understand the
significance and correlation of these factors. For example, future work could focus on the
132

creation of a predictive model with a target variable of actual CRDW use and predictor variables
that are correlated to actual use such as time, ease of use, type of support, and availability of
data. Part of the model creation would be a calculation of the significance of each of these
predictors within the model. The significance of the predictive factors could then inform
research to influence these predictors in order to increase actual use of the CRDW.

From a research protocol perspective, this study provides new protocols that can serve as a
foundation for objective measurement of technology use and adoption. One of the limitations
noted in research related to the technology adoption frameworks is the lack of objective
measures for actual technology use, because most studies have focused on measurements of
intention to use or likelihood to use. Within this study, both the likelihood to use and actual use
were measured using techniques that are common regardless of technology platform and can be
used retrospectively or prospectively (as done in this study). For example, while CTSA hubs
may have chosen different data warehouse implementations, most will have some form of
request process and audit trails. The process used in this study can be easily adapted based on a
CTSA hub’s specific technology implementation and used to review past and current activities
within the data warehouse.

Finally, the participation rates within this study were significantly higher than originally
anticipated. Several factors seemed to influence these rates. First, the assessment tools were
short and simple to complete. For example, both the awareness presentation and training
assessments were a page in length and included five questions or less. Second, assessments
occurred either during meetings or during a known timeframe (such as 30 days post-training).
As a result, participants did not need to find additional time in their schedules and/or could plan
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time within their schedules to complete the assessment. Finally, the background and reason for
each assessment were clearly described before participants agreed to complete the assessments.
This information proved important in participation decisions, as several individuals directly
expressed a desire to help with PhD research and/or assist in improving CRDW processes. In
future work, these factors should be considered when trying to assess potential participation
rates.

6.6

Study Finding Limitations

Although this study has several strengths and contributes to closing the gaps identified within the
literature corpus and practical implementation, several limitations of the findings need to be
noted.

First, the study period, especially the 30-day window for post-training follow-up, may have been
too short to completely assess CRDW use. Within this study, identifying that 30 days may be
insufficient is an important finding, as no baseline previously existed. An important next step in
exploring this topic should be understanding the “typical” timeline for use of the CRDW within
research projects.

Second, although this study exceeded the proposed sample sizes and participation rates, the
number of participants was still fairly small and did not include representation from all CTSI
partner institutions. This study was a first step in gathering information about CRDW use, but
further work is needed to fully reflect the experience of all CTSI partners as well as other CTSA
hubs.
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Finally, improvements to the research methodology were identified. For example, a question
related to planned activities within the CRDW would have assisted in understanding of changes
to trainees’ plans for using the CRDW within their research. Additionally, refinement of the
assessment item related CRDW tool ease of use is needed to gather more accurate information
about perceived ease of use. As a result, future research should incorporate these lessons learned
to gain further knowledge.

6.7

Future Research

Based on the findings from this study, several areas of future work have been identified.


Future research needs to focus on refining the objective measurement of “outcome
achievement.” This research may include focus groups with the target population to refine
the current definition, retrospective studies of audit trail data to obtain a timeline and baseline
of outcome achievement, and replication of this process focusing on use of different
technology platforms.



Research also needs to occur to better understand the timing of technology adoption. This
research may include interviews with individuals after awareness presentations to understand
how likelihood to use is linked to the timeline for requesting access and/or training, studies
identifying the typical time between access request and training request, and review of
CRDW activity to determine the typical activity pattern that appears within audit trails (e.g.,
do most users access the tool once or multiple times and how much time elapses between
uses).



Further research is needed to understand the significance and correlation of the factors
influencing CRDW use. This research may include extending this study to all CTSI partners
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and/or replicating this study with other CTSA hubs and providing more detailed
assessments/interviews specifically targeting significance and correlation.

6.8

Conclusion

Although significant research is being conducted about and with data warehouses for current and
future clinical and translational science purposes, critical gaps exist within the literature corpus
real-world implementation and practice. This study focused on three of these gaps: the need to
identify interventions that increase research team awareness of data warehouses, the need to
assess outcomes of data warehouse training, and the need to define objective measures for data
warehouse activities related to research outcome achievement.

To address these gaps, a study was conducted with the CTSI of Southeast Wisconsin focusing on
use of the CRDW. The study included an intervention to raise research team awareness of the
CRDW, assessments of the awareness intervention and existing CRDW training, and definition
and use of objective measures for completion of CRDW activities related to their intended
research outcomes after CRDW training. Four study components were included within the
study, and these components were based on four conceptual frameworks related to adoption of
technology and assessment of learning objectives: Diffusion of Innovation theory, Technology
Acceptance Model, DeLone and McLean Information Systems Success Model, and Bloom’s
Taxonomy of Educational Objectives.

Key study findings suggest that the awareness intervention and training were successful in
increasing research team knowledge of the CRDW and self-reported likelihood to use, but this
increase did not result in a subsequent increase in CRDW access requests or training requests
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within the study period. In addition, only 24% of trainees completed the CRDW activities
related to their intended research outcomes within 30 days of training. The time needed for
adopting the technology, the ease of use of the CRDW tools, the types of CRDW support
available, and the data available within the CRDW may all be factors influencing these
outcomes.

Although several study limitations have been noted, this study provides important findings
regarding attainment of technology knowledge and its links to actual technology use, the
correlation between self-reported likelihood to use and actual technology use, the timeline of
technology adoption, and foundational protocols for objective measurement of technology use
and adoption. Future research extending these findings should focus on refining the objective
measurement of “outcome achievement,” understanding the timing of technology adoption, and
measuring the significance and correlation of factors influencing CRDW use.
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APPENDIX A:

INSTITUTIONAL REVIEW BOARD APPROVAL LETTER

The following pages show the institutional review board (IRB) approval letter for this project.
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APPENDIX B:

AWARENESS PRESENTATION CONTENT

The following pages show the content covered during the awareness presentation (study
component #1) for this research study. The content and slides were developed by the BMI
Business Analyst, Kristen Osinski, and reviewed by the study researcher.
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APPENDIX C:

AWARENESS PRESENTATION ASSESSMENT TOOL

The following page shows the assessment tool used before and after the awareness presentation
(study component #1).
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APPENDIX D:

CRDW TRAINING ASSESSMENT TOOL

The following page shows the assessment tool used before and after the one-on-one/small group
CRDW training (study component #2).
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APPENDIX E:

30-DAY POST-TRAINING ASSESSMENT TOOL

The following pages show the assessment tool used 30 days after training was received (study
component #4). Although participants had the option of completing this assessment via
electronic survey or phone or in-person interview, the content of this assessment is shown as
formatted for the electronic survey in REDCap (with section numbers and additional information
added to describe the flow of the survey questions).
Section #1: Use of the CRDW Tools

If the answer to the previous question is Yes, the following additional questions appear:
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Section #2: Requesting Support

If the answer to the previous question is Yes, the following additional question appears:

Section #3: Benefits and Barriers to CRDW Use

Section #4: Likelihood to Use the CRDW

Section #5: Comments

169

CURRICULUM VITAE
Katie A. McCarthy, MSMI, CQIA(ASQ), CQSE(ASQ)
Milwaukee School of Engineering (MSOE)
1025 North Broadway, Milwaukee, WI 53202
Phone: 414-277-2316
Email: mccarthk@msoe.edu
Academic Degrees
Ph.D. in Health Sciences
Candidate (tentative: May 2019)
University of Wisconsin-Milwaukee
Milwaukee, WI
Area of concentration: Clinical and Health Informatics
M.S. Medical Informatics
May 2005
Milwaukee School of Engineering (MSOE)
Milwaukee, WI
Medical College of Wisconsin (MCW)
 Thesis: Discovering Helix – Implementing a Genome-enabled Laboratory
Information System
 Independent research: Bayesian networks applied to mammography diagnosis
B.S. Computer Engineering
B.S. Technical Communication
Milwaukee School of Engineering (MSOE)
 Fred Loock Outstanding Student Award
 Alumni Student Achievement Award
 Who’s Who Among Colleges and Universities

May 1999
May 1999
Milwaukee, WI

Professional Experience
Milwaukee School of Engineering (MSOE)
Milwaukee, WI

November 2005 to present

Assistant Professor, Rader School of Business
2013 to present
Adjunct Lecturer, Rader School of Business
2005 to 2013
 Served as Program Director for the M.S. Medical Informatics (MSMI) program,
jointly offered by MSOE and MCW
 Served as specialty coordinator for Bachelor of Business Administration (BBA)
Information Technology Systems (ITS) coordinator
 Served as academic advisor for MSMI, BBA-ITS, and B.S. Management Information
Systems (MIS) students
 Led curriculum redesign for the MSMI program, and co-led the curriculum creation
for the BBA program

170







Served as faculty advisor for the Quality and Efficiency module of the Clinical and
Translational Science Institute (CTSI) of Southeast Wisconsin
Served as faculty advisor for students participating in the Gus Ramirez Lean Scholars
Program through Froedtert and the Medical College of Wisconsin
Served as co-designer and instructor for the Rader School of Business Information
Technology summer program for high school students
Taught undergraduate and graduate courses for the following degree programs:
MSMI, Master of Business Administration (MBA), M.S. Nursing (MSN), M.S.
Engineering Management (MSEM), BBA, and B.S. Industrial Engineering
Courses taught in the following areas: informatics, analytics, data integration and
management, system development and implementation, quality improvement and
management, Six Sigma, Lean, design of experiments, statistics, healthcare
economics

Froedtert and The Medical College of Wisconsin
Milwaukee, WI

2006 to 2014

Information Technology (IT) Project Manager, Epic EMR Program
2011 to 2014
 Responsible for managing large Epic electronic medical record (EMR) projects,
involving large cross-functional teams and budgets of approximately $3 million.
 Projects managed included data conversion into Epic from two other EMRs,
implementation of more than 100 interfaces and negotiation of contracts with the
numerous vendors involved, implementation of anesthesia device integration with
Epic, redesign of Epic security for approximately 12,000 users, and design and
validation of a new framework for managing order transmittal for Epic.
IT Manager, Core Infrastructure Administration
2009 to 2011
 Responsible for management of approximately 50 employees that comprised the
telecommunications, data network, database, integration/interfaces, security and
disaster recovery, and Epic EMR core systems teams within the IT department.
 Responsible for operating budgets totaling over $5 million.
Clinical Informatics Team Lead – Orders and Results
2007 to 2009
 Responsible for leading team to design, implement, and maintain/support enterprise
ordering and resulting processes within the Epic electronic medical record, including
processes for laboratory, radiology, cardiology, medication, procedure, and referral
ordering.
 Responsible for analysis and design of interfaces to support laboratory, cardiology,
and medication processes.
 Responsible for daily team leadership, including team structure development, process
improvement, staff mentoring and training, and resource allocation.
Other positions held:
Clinical Informatics Systems Analyst
IT Systems Analyst

2006 to 2007
2006

171

BloodCenter of Wisconsin (BCW)
Milwaukee, WI

2001 to 2006

Positions held:
Diagnostic Laboratories Quality Engineer
Diagnostic Laboratories Lead Quality Specialist
Information Services (IS) Quality/Validation Analyst
 Responsible for daily oversight of the Diagnostic Laboratories Quality department
and the ongoing training and mentoring of the employees within the department,
including development of the new employee training program for the department.
 Responsible for creation and implementation of quality practices, management, and
tracking systems for individual departments, the Hematopoietic Progenitor Cell
(HPC) Program, and the Diagnostic Laboratories business unit (such as document
control, training, project management, resource tracking, change management, project
life cycle, validation, equipment tracking, and quality control and monitoring).
 Responsible for testing/validation of computer systems and applications, including
the lab information system (Cerner) and the blood operating system (LifeTrak).
 Responsible for daily quality activities, such as document creation and review; staff
training; creation and tracking of metrics; identification and implementation of
corrective actions; preparation of regulatory agency packets; facilitation of
departmental, internal, and external audits; and completion of audit responses.
 Responsible for creation and delivery of training such as Change Management,
Advanced Microsoft Word Skills, Quality Basics, Project Administration, Effective
Writing, and Statistical Techniques (Basic and Intermediate).
Plexus Technology Group
Neenah, WI

1999 to 2001

Embedded Software Design Engineer
 Responsible for the analysis, design, implementation, and testing of software for
medical devices, safety systems, and datacom/telecom products.
 Member of the Recruitment/Interview Team, the New Employee Training
Committee, and the Software Diagnostics and Testing Focus Group.

172

Publications and Presentations


Impact of Awareness and Training on the Adoption of Clinical Research Data Warehouses.
Katie McCarthy. American Medical Informatics Association (AMIA) Informatics Educators
Forum (IEF). June 2019 (accepted).



Merging Farms: Combining Two Instances of Epic. Bradley Howard, Katie McCarthy,
Kathy Patrino, and Michael Sura. Epic Users’ Group Meeting. September 2014.



Featured in Going from Epic to Epic: One Health System’s Unique Journey. Healthcare
Informatics. December 2013.



Cutover Planning and Implementation: Keys to a Successful Go-live. Katie McCarthy and
Nanda Kothinti. Epic Project Managers Advisory Council. April 2013.



Do Computer-Aided Diagnosis Systems in Mammography Need to be Trained to Individual
Observers? Charles Kahn, Katie McCarthy, and Elizabeth Burnside. Radiological Society of
North America (RSNA) Annual Meeting. November 2005.

Professional Affiliations


American Medical Informatics Association (AMIA)

2002 to present



American Society for Quality (ASQ)
Certified Quality Improvement Associate (CQIA)
Certified Software Quality Engineer (CQSE)

2001 to present
2003 to present
2002 to present



Association for Computing Machinery (ACM)

2000 to present



Healthcare Information and Management Systems Society (HIMSS)

2006 to present

Honors


MSOE Falk Engineering Educator Award (finalist)

2014, 2015



MSOE Outstanding Mentor Award (nominee)

2000, 2002

Community and Professional Involvement


MSOE Nursing Advisory Committee, Member

2017 to present



BloodCenter of Wisconsin (BCW)
Lecturer for Specialist in Blood Banking (SBB) program

2004 to present



Third Coast Consortium for Biomedical and Health Informatics
Co-organizer

2015 to 2017



HIMSS Dairyland Regional Networking event
Co-organizer

2014 to 2017

173

Professional Development


Massachusetts Institute of Technology (MIT)
Professional development certificate: Big Data and Social Analytics

2016



Blackboard Learning Management System
Webinar: The Ins and Outs of Designing Exemplary Courses

2015



Massachusetts Institute of Technology (MIT)
Professional development course: Tackling the Challenges of Big Data

2016



ACM Computer-Human Interaction (CHI) conference

2014



Epic User Group Meeting (UGM)



Epic Project Managers Advisory Council

2013



ASQ World Conference for Quality and Improvement

2006



Cerner Healthcare Conference

2004



MSOE Quality Engineer training

2004



ASQ Quality 101 training

2003



ASQ Software Quality Engineering training

2002

2009, 2013, 2014

174

